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Abstract 
The incidence of cardiovascular pathologies has been correlated with decreased levels of 
sex hormones. Beneficial effects of androgens on vascular function have been demonstrated 
by modulating the release and function of factors involved in vascular tone regulation. On the 
other hand, numerous studies support the cardioprotective properties of ω-3 polyunsaturated 
fatty acids (PUFAs), with docosahexaenoic acid (DHA) being one of the most studied. 
Considering the pathophysiological effects observed as a consequence of the lack of sex 
hormones and the beneficial cardioprotective properties of the specific ω-3 PUFA, DHA, the 
current thesis investigated whether a diet supplemented with DHA could prevent the 
orchidectomy-induced alterations in vascular function from male rats. For this purpose, control 
and orchidectomized rats, fed with a standard diet, and orchidectomized fed with a 
supplemented diet with 5 % (w/w) DHA, were used to analyze: (1) the lipid profile, (2) the 
formation of cholesterol oxidation products (COPs), (3) redox status, and (4) inflammatory 
factors. In addition, responses to specific stimuli in isolated conductance and resistance 
vascular beds were also studied. 
The results showed that the DHA supplemented diet prevented vascular dysfunction 
produced by the loss of gonadal function in male rats, since it restored the lipid profile 
negatively affected by the orchidectomy, prevented the orchidectomy-induced COPs increase, 
decreased hydrogen peroxide formation and increased antioxidant capacity in serum and 
aortic tissue. In addition, DHA-supplemented diet decreased the production of superoxide 
anion (increased by orchidectomy) in aorta and mesenteric artery, which may contribute to 
restore the NO production and bioavailability in these arteries. Also, DHA diet decreased 
prostanoid production in aorta and mesenteric arteries from orchidectomized rats. DHA also 
contributed to preserve vascular function, through the improvement of neurogenic responses 
in the mesenteric artery and in the participation of hyperpolarizing mechanisms in aorta. 
Overall, these results show that a DHA-supplemented diet exerted a cardioprotective effect in 
physiopathological conditions in which vascular dysfunction exists.  
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Resumen 
La incidencia de patologías cardiovasculares se ha correlacionado con niveles disminuidos 
de hormonas sexuales. Así, se han descrito que los andrógenos ejercen efectos beneficiosos 
sobre la función vascular mediante la modulación de la liberación y función de factores 
implicados en la regulación del tono vascular. Por otro lado, numerosos estudios apoyan las 
propiedades cardioprotectoras de los ácidos grasos poliinsaturados ω-3, siendo el ácido 
docosahexaenoico (DHA) uno de los más estudiados.  
Teniendo en cuenta los efectos fisiopatológicos observados como consecuencia de la falta 
de hormonas sexuales y las propiedades cardioprotectoras de los ácidos grasos ω-3, 
específicamente del DHA, en la presente tesis se investigó si una dieta suplementada con DHA 
podría prevenir las alteraciones inducidas por la orquidectomía en la función vascular de ratas 
macho. Para este propósito, se utilizaron ratas control y orquidectomizadas alimentadas con 
una dieta estándar y orquidectomizadas alimentadas con una dieta suplementada con DHA, 
5% (p/p), para analizar: (1) el perfil lipídico, (2) la formación de productos de oxidación del 
colesterol (COPs), (3) estado redox y (4) factores inflamatorios. Además, se estudiaron las 
respuestas a estímulos específicos en lechos vasculares de conductancia y de resistencia.  
Los resultados mostraron que la dieta suplementada con DHA previene la disfunción 
vascular producida por la pérdida de la función gonadal en ratas macho, ya que restauró el 
perfil lipídico, afectado negativamente por la orquidectomía, impidió el aumento de COPs 
inducido por orquidectomía y disminuyó la formación de peróxido de hidrógeno, a la vez que 
aumentó la capacidad antioxidante (ejerciendo así propiedades antioxidantes) en suero y 
tejido aórtico. Además, la dieta suplementada con DHA disminuyó la producción del anión 
superóxido (aumentado por la orquidectomía) en aorta y arteria mesentérica, lo que 
probablemente contribuyó a restaurar la producción y biodisponibilidad del óxido nítrico en 
estas arterias. Además, el DHA ejerció propiedades antiinflamatorias, ya que disminuyó la 
producción de prostanoides en aorta y arteria mesentérica de ratas orquectomizadas. El DHA 
también contribuyó a preservar la función vascular, participando en la mejora de las 
respuestas neurogénicas de la arteria mesentérica y en la participación de mecanismos 
hiperpolarizantes en la aorta. En general, estos resultados muestran que una dieta 
suplementada con DHA ejerce un efecto cardioprotector en condiciones fisiopatológicas en las 
que existe disfunción vascular. 
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Cardiovascular diseases 
Cardiovascular disease is a collective term that constitutes a group of disorders of the 
heart and blood vessels. According to the World Health Organization (WHO) cardiovascular 
diseases (CVD) are the leading cause of death worldwide [1]. In the spanish population, one of 
every three deaths is caused by CVD, age-adjusted mortality rates for these pathologies have 
been decreasing since 1975 by 3.1% per year [2]. In contrast, rates of hospital morbidity due to 
CVD have almost tripled in Spain during this period due to the increase in obesity and diabetes 
incidence, coupled with increased patient survival and aging in the general population, 
although it seems to have stabilized since 2002 [3]. The CVDs with the highest incidence are 
cerebrovascular disease in women and ischemic heart disease in men [2]. 
CVD occurrence is determined by multiple factors and their interactions. It is well 
established from the Framingham study, the importance of several modifiable CVD risk factors, 
among which we can highlight hypertension, hypercholesterolemia, smoking and diabetes 
mellitus and others, such as hypertriglyceridemia, obesity and sedentary lifestyle that also play 
a relevant role [4–6]. However, some risk factors, including age, gender or family 
history/genetic predisposition, are immutable [7]. Additionally, cultural and psychosocial 
factors, e.g. education, economic and marital status, also access to health care, contribute to 
the development of CVDs [1]. Therefore, the combination of lifestyle and the risk factors 
associated with the development of CVD is related to its higher incidence. Thus, the control of 
these CVD risk factors and the modification in the habits of life can delay or even sometimes 
avoid the appearance of these conditions. Additionally, the effect of sex hormones seems to 
influence the incidence of CVD, which will be described in the “Sex hormones and regulation of 
vascular tone” section. 
Nowadays, there are numerous cardiovascular risk prediction biomarkers. It is well 
stablished that a standard lipid profile including total cholesterol, LDL (low density lipoprotein) 
cholesterol, HDL (high density lipoprotein) cholesterol and triglycerides, is recommended to 
predict the risk to develop a CVD. Also, glucose and hormones levels can be correlated with 
CVD incidence. In addition, atherosclerosis is a common pathophysiological condition present 
in several CVD, since it is a multifactorial disease whose onset influences various CVD-risk 
factors (hypertension, hyperlipidemia, etc.), that interact synergistically and tend to be 
associated in some individuals. Moreover, various cardiovascular risk prediction models have 
been updated by incorporating traditional risk factors and molecular, immunological, genetic, 
Introduction 
2 
 
imaging, and biophysical factors for more authentic and reliable estimation of cardiovascular 
risk [8]. 
Cholesterol as a cardiovascular risk factor 
Cholesterol is one of the major components of cell membranes and is involved as a 
substrate in the synthesis of steroid hormones and bile acids. To perform their functions, all 
cells require cholesterol, obtained by de novo biosynthesis, or by taking it from the 
lipoproteins present in the plasma. Cholesterol is vital in the body, but when it is found in 
excess dyslipidemia may appear. These alterations can be of dietary or genetic origin, also the 
existence of alterations in the synthesis of cholesterol or in its transporting lipoproteins may 
be involved [9]. 
In hypercholesterolemia, cholesterol accumulates in the lipid bilayers from different 
types of cells, including erythrocytes, platelets, leukocytes, polymorphonuclear cells, and 
endothelial cells. These cholesterol molecules are largely susceptible to oxidation, leading to 
the formation of cholesterol oxidation products (COPs) or also known as oxysterols [10]. The 
oxidation of this unsaponificable molecule affects the properties and the dynamics of the lipid 
bilayers by causing minor changes in the chemical structure of cholesterol, which in turn 
influences cell signaling [11–13]. 
In biological systems the transformation of cholesterol into its oxidized derivatives 
occurs trough non-enzymatic or enzymatic reactions. Generally, oxysterols differ from 
cholesterol by one or several additional polar groups, which typically include a hydroxyl, keto, 
hydroperoxy, epoxy, or carboxyl group. In Figure 1 the main biologically relevant oxysterols are 
represented. 
Non-enzymatic cholesterol oxidation, also known as cholesterol auto-oxidation is given 
by its reaction with reactive oxygen species (ROS), which are physiologically present in the 
organism [14]. In this respect, the oxidation of cholesterol is similar to that occurred in other 
lipids, also prone to attacks by ROS [15,16]. 
As well, cholesterol can be oxidized through to the action of several enzymes [17,18] 
mostly related to the cytochrome P450 family. Among them, CYP7A1 and CYP27A1, take part 
in the synthesis of 7α-hydroxycholesterol (7α-OH) and 27- hydroxycholesterol (27-OH), 
occurred predominantly in the liver [19]. Cholesterol 25- hydroxylase, which is a non heme-
iron-containing enzyme present in most tissues, catalyzes the formation of 25 
hydroxycholesterol (25-OH) [18].  
Introduction 
3 
 
In addition, exogenous oxysterols can be absorbed from dietary sources [20] and enter 
circulation[15,21]. 
 
 
Figure 1. Chemical structures of the main oxysterols formed enzymatic and non-enzymatic 
pathway [22]. Cholesterol is predominantly modified at carbon 7, leading to the formation of 
7α-OH and 7β-hydroxycholesterol (7β-OH) and 7-ketocholesterol (7-keto), recognized as the 
main products of cholesterol autoxidation. Cholesterol is also commonly modified in carbons 5 
and 6 to form 5β,6β-epoxycholesterol (5β-E), 5α,6α-epoxycholesterol (5α-E) and 5α,6β-
dihydroxycholesterol. In a lesser extent, the oxidation of the side chain generates 
monohydroperoxides in positions 20, 22, 24, 25 and 26, leading to the formation of hydroxyl 
derivatives, comprising oxysterols of biomedical interest, although they are generally 
considered to not represent significant products of the autoxidation of cholesterol [14,15,23]. 
 
Lipid peroxidation induces disturbance of fine structure, alteration of integrity, fluidity, 
and permeability, and functional loss of biomembranes. The growing evidence implicates the 
accumulation of cholesterol metabolism end products as mediators of lipid metabolism, 
inflammation, potent oxidative stress inducers, cell death, and autophagy on different cell 
types [22]. In addition, the reactive carbonyl compounds, the secondary products of 
oxysterols, modify proteins and DNA bases, showing mutagenic and carcinogenic properties 
[24]. In fact, many studies report increased levels of oxysterols products in biological tissues 
and fluids of patients in pathologies including atherosclerosis, cardiovascular diseases, cancer, 
neurological disorders [25,26], metabolic syndrome, osteoporosis, macular degeneration, 
inflammatory bowel diseases, diabetes, kidney failure, ethanol intoxication [27] and in 
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physiological conditions characterized by altered cholesterol uptake and/or metabolism like 
aging [28]. 
General structure of the vascular wall 
Blood vessels withstand the pressure of circulating blood trough the body, distribution 
of nutrients, gases, removal of waste products and thermoregulation, providing the main link 
between the heart and tissues. The arterial wall contributes to the maintenance of vascular 
homeostasis, since it responds actively to a variety of stimuli. The mechanisms involved in the 
regulation of vascular tone are diverse, in which endothelial, muscular, nervous and hormonal 
factors are involved [29]. 
The vascular wall consists of three layers; the intima (inner layer), the tunica media 
(middle layer) and the adventitia (outer layer) (Figure 2). Vasomotor control, as well as the 
vascular structure, are influenced synergistically by each of the layers, in which the final effect 
is the result of the interconnected participation of the three arterial layers [30]. 
The endothelium is a monolayer of cells that delimitates the inside of the vascular wall, 
which is composed by the intima layer along with its connective tissue. The endothelium forms 
a barrier between the circulatory content and the surrounding vascular tissue. It regulates 
vascular tone by affecting the balance between dilatation and constriction of vascular smooth 
muscle cells (VSMCs). It also controls a variety of other intravascular processes such as 
proliferation and migration of VSMCs, leukocyte and platelet adhesion and aggregation, as well 
as the balance between thrombogenesis and fibrinolysis [31]. The endothelial function refers 
to the homeostasis of this set of physiological mechanisms, which is maintained by the 
synthesis and release of multiple vasoactive mediators. Among the vasodilator and anti-
atherogenic factors participating in this function is the nitric oxide (NO), the prostacyclin (PGI2) 
and the endothelium derived-hyperpolarizing factor (EDHF). On the other hand, the 
vasoconstricting and pro-atherogenic substances of this function involve prostanoids, such as 
thromboxane A2 (TXA2), ROS, angiotensin II (Ang II) and endothelin-1 (ET-1) [32]. It is known 
that endothelial cells are sensitive to hemodynamic changes, which combined with the action 
of the released factors maintain vascular homeostasis. 
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Figure 2. General structure of the arterial wall. Adapted from Martinez-Lemus [33]. The 
arterial wall is a heterogeneous, three-layered structure composed of an intima, media, and 
adventitia. Each layer displays specific histological, biochemical, and functional characteristics, 
to contribute in maintenance of vascular homeostasis and vascular response regulation to 
stress or injury. 
 
Endothelial dysfunction is an imbalance between vasoconstrictor and vasodilator 
mediators [34], resulting in the loss of selective barrier function, a greater tendency for 
platelet aggregation and thrombosis, increased leukocyte adhesion, vasoconstriction, as well 
as migration of VSMCs into the inner layer of the vessels. Endothelial dysfunction is probably 
the first step towards hypertension and atherosclerosis and it is associated with numerous 
CVD. Also, is closely related to other pathologies such as hyperlipidemia and diabetes, 
smoking, obesity, age or sedentary lifestyle [35]. 
The tunica media is the middle layer and primarily consists in a very marked layer of 
VSMCs fibers with reticular fibers associated therewith and a small number of individual elastic 
fibers. Vascular smooth muscle constitutes the major part of this layer in blood vessels and 
plays an important role in the regulation of vascular resistance and blood pressure, and its 
deregulation can lead to vascular diseases, including hypertension and coronary artery disease.  
Vascular muscle cells are fusiform elongated cells with an enlarged nucleus, and 
contain actin and myosin myofibrils, responsible for contraction due to the displacement of 
actin on myosin filaments. The contractile process is driven by the increase of cytoplasmic 
concentration of Ca2+ ([Ca2+]i) and/or by activation of different protein kinases [36–38] Also, 
VSMCs are able to produce different vasoactive substances, including prostanoids, growth 
factors, ROS, cytokines, among others. 
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The tunica adventitia is the outermost layer of the vessel wall, surrounding the tunica 
media. The adventitia is predominantly made up by extracellular matrix (type I collagen and 
elastic fibers), nutrient vessels (vasa vasorum), autonomic nerves (nervi vasorum) and adipose 
tissue [39,40]. Fibroblasts and numerous macrophages are also present in this layer. The tunica 
adventitia helps to anchor the vessel to the surrounding tissue. The adventitia actively 
participates in the regulation of vascular tone, since it is a source of fatty acids, adipokines and 
ROS, which affect vascular smooth muscle function [41]. 
The nerve endings that reach the adventitial tunica have great importance in the 
control of vasomotor responses. Between the nerve endings and the vascular cells, chemical 
communication is established through the synaptic cleft. This type of communication is 
characterized by the release of neurotransmitters from the nerve endings, and by the 
interaction of these neurotransmitters with specific receptors located in the postsynaptic cell.  
A brief review of the main factors involved in the regulation of vascular function will be 
presented below. 
Nitric oxide 
NO is a small gas molecule that plays a key role in every system of the organism. Given 
the importance of this molecule in the regulation of vascular tone it has been widely studied, 
and the mechanisms related to its synthesis, release, metabolism and the mechanism of action 
are very well known [32]. The NO biosynthesis is catalyzed by three different isoforms of the 
NO synthase enzyme (NOS) of which there are two constitutive isoforms called endothelial 
NOS (eNOS), present mainly in the endothelium, endocardium and myocardium [42] and 
neuronal NOS (nNOS) present in the central and peripheral nervous system and also in 
cardiomyocytes [43], which are Ca2+-calmodulin dependent. The third inducible isoform, called 
inducible NOS (iNOS) is located in different cell types, is Ca2+ and calmodulin independent, and 
can be induced by cytokines or bacterial endotoxins [44]. 
In the synthesis of NO, NOS hydroxylates the L-arginine to Nω-hidroxy-L-arginine 
(which remains largely bound to the enzyme). In a second step, NOS oxidizes Nω-hidroxy-L-
arginine to L-citruline and NO using nicotinamide adenine dinucleotide phosphate (NADPH) as 
an electron donor [45]. The three isoforms of the NOS enzyme go through these two stages for 
the synthesis of NO. eNOS can also be stimulated pharmacologically, by endothelium-
dependent vasoactive substances, which can influence the enzyme detachment from caveolin 
by releasing Ca2+ from the endoplasmic reticulum. Examples of these substances include 
bradykinin (BK), acetylcholine (ACh), adenosine triphosphate (ATP), adenosine diphosphate 
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(ADP), substance P and thrombin [46]. The enzyme can be inhibited by a wide variety of 
substances, e.g. L-arginine analogs, like the Nω-monomethyl-L-arginine (L-NMMA) or Nω-nitro-
L-arginine methil esther (L-NAME). 
NO derived from eNOS is importantly involved in the maintenance of basal vascular 
tone [47], but may also confer vasoprotection, since it is a homeostatic regulator of essential 
cardiovascular functions. NO causes relaxation in blood vessels by stimulating soluble guanylyl 
cyclase (sGC) and increasing cyclic guanosine monophosphate (cGMP) in smooth muscle cells 
(Figure 3) [48,49].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of VSMc relaxation by NO. Adapted from Paul & Snyder 
[50]. NO diffuses rapidly through tissues such as VSMCs; NO causes a conformational change in 
the sGC to increase activity of this enzyme [48,51]. The sGC converts the guanosine 
triphosphate (GTP) into cGMP, which in turn activates the protein kinase G (PKG). 
Phosphorylation of the Ser and Thr residues from the PKG activates or inhibits the function of 
different proteins to decrease [Ca2+]i and produces relaxation in the fiber through different 
mechanisms, such as the activation of the Ca2+-ATPase of the sarcoplasmic reticulum by 
introducing Ca2+ into the reticulum [52], the regulation in the phosphorylation and activation 
of the Ca2+ -ATPase of the plasma membrane, releasing Ca2+ to the outside of the cell [53], 
closure of the plasma membrane voltage-dependent Ca2+ channels [54], the inhibition of Ca2+ 
release from the reticulum induced by phosphorylation of inositol trisphosphate (IP3) [55], 
activation of Na+/K+ ATPase [56], activation of Ca2+ -dependent K+ channels (Robertson et al., 
1993), stimulation of Na+/Ca2+ exchanger [57]. In addition, it has been reported that NO can 
hyperpolarize the smooth muscle cell membrane and thus cause vasodilation by direct 
activation of K+ channels [58]. 
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eNOS can also induce a long-lasting release of NO in an intracellular Ca2+-independent 
manner. In vascular endothelium, the best stimulus to activate eNOS for the generation and 
release of NO, is the hemodynamic stimuli exerted on the luminal surface of endothelial cells 
by the streaming blood (shear stress) [59]. This activation of eNOS is mediated by 
phosphorylation in various residues of serine (Ser), threonine (Thr) and tyrosine (Tyr) through 
protein kinases [60]. Also, NO is a potent inhibitor of platelet aggregation and adhesion to the 
vascular wall [61,62], which in turn exerts anti-proliferative mechanisms by avoiding the 
release of platelet-derived growth factors. eNOS is also essential in adaptive vascular 
remodeling in chronic changes of flow [63] and controls the expression of genes involved in 
atherogenesis [64], participates in mRNA translation [65] and produces post-translational 
protein modification [66]. 
The NO produced by nNOS in the nitrergic nerves acts as a neurotransmitter that 
stimulates the NO-responsive GC in its effector cells, thus decreasing the tone of various types 
of smooth muscle including blood vessels [67,68]. 
Inducible NOS is not commonly expressed, but can be induced by cytokines and other 
agents (lipopolysaccharides) in almost any cell type. Unlike eNOS and nNOS, iNOS is constantly 
active once expressed, and is not regulated by [Ca2+]i. However, the expression of the iNOS and 
the NO generated by this enzyme mediate various symptoms in inflammatory diseases [69]; 
the major cytotoxic effect on phagocytes due to the production of large amounts of NO, 
leading to DNA breakage and fragmentation in its target cells (i. e. microorganisms and tumor 
cells) [70,71]. In addition, inducible NOS-derived NO is the main mediator of vasodilation and 
the drop in blood pressure observed in septic Shock [72]. The levels of NO released from iNOS 
is much higher compared to the other two NOS isoforms [73]. 
Endothelium-dependent hyperpolarizing factor 
The endothelium also releases a relaxation-inducer substance in vessels by 
hyperpolarizing the muscle membrane, called the endothelium-dependent hyperpolarizing 
factor (EDHF) [74]. Currently, EDHF is attributed to several completely different mechanisms, 
not just one, ranging from K+ [75] to H2O2 [34] (Figure 4). The activity of EDHF is not mediated 
by NO or cyclooxygenase (COX) -derived prostanoids, but it is blocked, at least partially, by 
inhibitors of K+ channels. Endothelium-dependent hyperpolarization is substantially due to the 
opening of the K+ channels in the VSMCs, determining the K+ flux and consequent 
hyperpolarization of the cell membrane. This, in turn, induces a decrease in the influx of Ca2+, 
which results in vasorelaxation [76].  
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Figure 4. Schematic representation of the mechanisms likely involved in endothelium-
derived hyperpolarization. Mechanisms for endothelial cell mediated relaxation. Agonist 
(bradykinin/acetylcholine/substance P) or shear stress increases the activity of eNOS and COX, 
providing NO and PGI2-mediated dilation. There are multiple potential EDHF pathways. [Ca+2]i 
activates PLA2 to produce AA. Its metabolism by cytochrome P450 2C (CYP4502c) generates 
eicosatrienoic acids (EETs) that can stimulate calcium-dependent potassium (KCa) channels in 
endothelial and smooth muscle cells. EETs may also directly activate gap junctions (Gap). EETs 
may also act in an autocrine manner on endothelial cells by activating transient receptor 
potential (TRP) V4 channels, which promote Ca+2 influx further increasing the calcium 
concentration and activating KCa channels to cause hyperpolarization and release of K+ ions into 
the subendothelial space. The increase in potassium in the interstitium may activate 
KCa +channels, inwardly rectifying potassium channels (KIR +), or the Na+-K+ pump on smooth 
muscle cells and cause hyperpolarization. Smooth muscle hyperpolarization in turn results in 
relaxation by closing voltage-gated channels leading to a fall in Ca+2 concentration and 
subsequent vasodilation. The action of eNOS (with cofactor tetrahydrobiopterin [BH4]) and 
oxidases on oxygen (O2) produces the reactive oxygen species superoxide (O2−). Hydrogen 
peroxide (H2O2) generated by dismutation of superoxide anions by SOD can also cause 
hyperpolarization by activating endothelial and smooth muscle KCa channels or by gap 
junctions. Adapted from Ozkor et al. [77]. 
 
The endothelium and smooth muscle express a variety of different K+ channels, Ca2+ 
and ATP-dependent channels (KCa and KATP respectively), voltage-dependent (KV), two pore 
domain (K2P) and input rectifiers (KIR). Their contribution to the numerous mechanisms of 
endothelium-dependent relaxation and smooth muscle are closely related to their 
electrophysiological properties and mechanisms of activation within the vascular wall. 
Therefore, K+ channels play an important role in the regulation of blood pressure. Mechanisms 
of action of EDHF include: (a) synthesis of cytochrome P450 (CYP450) labile metabolites, a 
family of epoxides, (b) transmission of endothelial cell hyperpolarization to the vascular 
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smooth muscle via gap junctions, and (c) K+ released from the endothelial cells via KCa or KATP 
channels induces smooth muscle hyperpolarization by activating KCa channels and/or Na+-K+-
ATPase on vascular smooth muscle cells. Hydrogen peroxide (H2O2) is involved in KCa channels 
activation, therefore considered as an EDHF. Also, some non-NO gaseous agents, such as 
carbon monoxide (CO) and hydrogen sulphide (H2S) which might act as autocrine and/or 
paracrine agents to produce hyperpolarization [78,79]. The contribution of EDHF to 
endothelium-dependent relaxation varies depending on the artery studied. This factor plays a 
fundamental role in resistance vessels, thus appears to play an important role in local 
regulation of peripheral vascular resistance [80]. Additionally, their participation is modified in 
pathophysiological situations in which NO bioavailability is diminished, acting as a reserve 
system for endothelial vasodilator factors, even in conductance vessels [75,81,82]. 
Prostanoids 
Prostanoids are synthesized by COX from arachidonic acid (AA), a 20-carbon 
unsaturated fatty acid. Prostanoids biosynthesis begins with the release of AA from membrane 
phospholipids by the action of phospholipase A2 (PLA2) or the diacylglycerol (DAG) [83]. AA is 
converted to prostaglandin G2 (PGG2), which is subsequently peroxidized to prostaglandin H2 
(PGH2). The catalysis of these reactions is carried out by the COX, adding two molecules of O2 
to AA for the generation of PGG2. Subsequently, the peroxidase activity catalyzes the reduction 
of PGG2 to PGH2 (Figure 5) [84]. 
There are two isoforms of the enzyme cyclooxygenase, COX-1 and COX-2, encoded by 
two different genes, and it is associated with the luminal side of the endoplasmic reticulum 
and the nuclear membrane [85]. Both isoforms are expressed in endothelial cells and in VSMCs 
[86]. COX-1 is located on the membrane of the endoplasmic reticulum, constitutively 
expressed in most tissues [87]. It is the predominant isoform under static conditions or under 
chronic shear stress [88,89]. Also, plays a very important role in different physiological 
functions, including platelet aggregation and renal function [90]. The COX-2 isoform is found in 
the nuclear membrane at very low levels. However, it is immediately induced by mitogenic and 
pro-inflammatory stimuli, such as cytokines (interleukin-1β) and endotoxins 
(lipopolysaccharides) in endothelial cells, smooth muscle cells and fibroblasts [91–93]. 
However, COX-2 is also expressed constitutively in different cell types, including endothelial 
cells, in which its expression is also regulated by mechanical stress [94]. Also, it has been 
described an enzymatically active COX-1 splicing variant called COX-3, expressed in the heart 
and cerebral cortex, but the regulation of its transcription seems similar to that of COX-1 [95].  
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PGH2 is the substrate of the different synthases for the production of different 
prostanoids (Figure 5). The bioactive prostanoids are the prostaglandin (PG) E2, PGF2α, PGD2, 
PGI2, and thromboxane A2 (TXA2) [86]. Prostanoids interact with their specific receptors, which 
are coupled to heterotrimeric G proteins that modulate second messengers, such as cAMP or 
IP3 at the intracellular level. However, the effect of each prostanoid will depend on the cell 
type, physiological situation, concentration or whether it binds to another receptor from the 
same family of proteins, which may result in an opposite effect [96]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Arachidonic acid metabolism towards specific prostanoids. Formation of 
prostanoids from AA by the action of COX-1/2. The specific effects of each prostanoid occur 
through the activation of the specific receptors (IP, TP, DP, EP and FP).  
 
PGE2 is the predominant product of COX in microvascular endothelial cells [97] and in 
general is the most abundant prostaglandin in the human body. This molecule exerts 
reproduction, neuronal, metabolic and immune functions [98]. Among its physiological effects, 
comprises the regulation of blood pressure through VSMCs relaxation and contraction, 
depending on the activated receptor. These effects can be attributed to the existence of four 
receptor subtypes, EP1, EP2, EP3 and EP4, which are coupled to different signaling pathways 
[96,98,99]. Activation of EP1 is associated with contraction [100,101]. In contrast, activation of 
EP2 and EP4 receptors leads to vasodilation [102]. PGE2 activates platelets through EP3 and 
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possibly EP1, but at high concentrations it may inhibit its aggregation by stimulating the IP and 
TP receptors [103]. 
The PGF2α isoforms are synthesized from PGH2, and also from PGD2 and PGE2 
[104,105]. PGF2α interacts with the FP receptor, which generally causes an increase in [Ca2+]i 
and vasoconstriction. The PGF2α-induced activation of TP receptors has been involved in the 
development of cardiac hypertrophy [96,106,107]. Additionally, FP receptor stimulation can be 
expressed in endothelial cells and induce endothelial NO release [108]. 
Prostacyclin is an unstable substance formed by prostacyclin synthase, which is highly 
expressed in endothelial cells [101]. It is also found in cardiac and VSMCs, among other cell 
types [109]. It is a potent platelet inhibitor, which prevents its aggregation and adhesion to the 
surface of endothelial cells. Prostacyclin is the preferential ligand of IP receptors, producing 
vasodilatory effect [83] by reducing intracellular Ca2+ in muscle cells by the action of cAMP 
after activation of adenylate cyclase (AC). cAMP induces the phosphorylation of protein kinase 
A (PKA) producing the inhibition of Ca2+-calmodulin dependent contractile mechanisms [110] 
by inhibiting the release of Ca2+ from the reticulum by the phosphorylation of the IP3 receptor. 
Therefore, in numerous of vascular beds, PGI2 may act not only as an endothelium-derived 
relaxing factor, but also as a hyperpolarizing substance derived from the endothelium, since it 
activates K+ channels [34,111]. In addition, prostacyclin is also a potent anti-proliferative agent 
in vascular smooth muscle cells, reduces oxidative stress and prevents cell adhesion to the 
vascular wall [109]. It has been shown that PGI2 levels are increased in patients with 
atherosclerosis [112], and under experimental conditions of hypertension [82,113]. The 
vasodilatory effect induced by low concentrations of PGI2 turns into vasoconstrictor due to the 
increased production, whereas at high concentrations the effect is vasoconstrictor [83,113]. 
TXA2 is synthesized by the action of the enzyme thromboxane synthase and it is rapidly 
metabolized into TXB2. In the cardiovascular system, TXA2 is derived from COX-1, which is 
synthesized in endothelial and smooth muscle cells [94], but it can also be produced by COX-2 
in the vascular wall [114]. TXA2, like all prostanoids, exerts its actions through its specific 
receptor, called TP, of which two different isoforms called α and β are known, distinguished 
from each other at the carboxy- end located inside the cell [115]. The release of TXA2 and 
other vasoconstrictor PGs can be stimulated by different vasoconstricting agents such as ET-1, 
serotonin (5-HT), noradrenaline (NA) and Ang-II, as well as vasodilator agents, like ACh, and 
other substances such as nicotine and ionophore A23187 [116,117]. Thus, TXA2 can participate 
in the endothelial dysfunction associated with cardiovascular disease [118]. TXA2 activates its 
specific receptor, TP, which is functionally coupled to a G protein. The activation of these 
components inhibits the AC, leading to a decrease in cAMP levels [115]. Activation of TP 
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receptors also induces the activation of phospho lipase C (PLC). PLC catalyzes the 
transformation of phosphatidylinositol-4,5-bisphosphate (PIP2) into DAG and IP3, resulting in 
the release of stored Ca2+ and PKC activation respectively, leading to the contraction of the 
smooth muscle cells [119]. In addition to the activation of these signaling pathways, TXA2 
induces platelet aggregation and VSMCs contraction, hypertrophy and cell proliferation [120]. 
TXA2 is also related to hypertension, atherosclerosis, myocardial infarction and in general to 
the development of CVD [121]. 
Reactive oxygen species 
Reactive oxygen species (ROS), such as superoxide anion (O2-•), hydrogen peroxide 
(H2O2) and hydroxyl radical (-OH), are generated by the cell normal metabolism. ROS have a 
significant role as intracellular signaling molecules and as paracrine messengers in 
physiological and pathological processes. Both the endothelial cells [122–125] and smooth 
muscle cells [123,126] generate significant amounts of ROS, spontaneously or in response to 
receptor-mediated or non-receptor-mediated stimuli. Under normal conditions, there is a 
balance between the formation and removal of ROS by antioxidants. However, an imbalance 
between pro-oxidants and antioxidants results in oxidative stress, which has been associated 
with multiple pathologies, including CVD [127]. In the vascular system, ROS can modulate the 
tone and structure from blood vessels, which can increase the growth of VSMCs, cell 
migration, inflammation and deposition of cellular matrix proteins, resulting in a vascular 
remodeling process, including endothelial dysfunction and thickening of the vascular wall 
[128]. 
The O2−• has a very reactive unpaired electron, which causes high instability and very 
short life time of the molecule. Superoxide anion is generated through the reduction of 
molecular oxygen by different enzymes, such as NADPH oxidase, xanthine oxidase, COX, NOS, 
cytochrome P450 monooxygenase, mitochondrial respiratory chain enzymes, in all cell types, 
including VSMCs and endothelial cells [129–131]. Additionally, the three isoforms of NOS are 
capable of producing O2−• by a process called uncoupling [132,133], which consists of electrons 
transfer to O2, instead of L-arginine. 
O2−• reacts rapidly with NO and consequently reducing its half-life and starts the 
production of ONOO-. ONOO- effects negatively producing a reduction in basal vasodilator 
tone, unbalancing the blood pressure control, increasing oxidative stress and producing 
endothelial damage [134]. Moreover, O2−• exerts vasomotor actions, since vasodilator and 
vasoconstrictor effects have been reported [135,136]. In small doses it can stimulate COX 
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causing the release of PGI2, resulting in a vasodilator effect. On the other hand, at higher 
concentrations PGI2 formation is inhibited, negatively affecting the balance in the vascular 
tone by stimulating the formation of PGF2and TXA2. 
O2−• can be reduced to H2O2, either spontaneously or enzymatically through 
dismutation by superoxide dismutase (SOD). In presence of the enzyme catalase or glutathione 
peroxidase, H2O2, is disrupted in water and oxygen. H2O2 is a stable molecule which can 
perform its effects locally near its production site, or diffuse through the cell membrane, since 
it is fat soluble can exert its effect on neighboring cells. This molecule modulates different 
aspects of endothelial cell function, such as growth and proliferation, apoptosis, cytoskeletal 
reorganization, inflammatory responses, vascular remodeling and regulation of endothelium-
dependent vascular tone. H2O2 may possess dilating and constricting properties depending on 
tissue, experimental conditions or concentration [134]. Indeed, O2−• and H2O2 stimulate 
contraction after mobilizing the stored [Ca2+]i, and activating the Na+/H+ exchanger [77]. 
However, on precontracted vessels, ONOO- and H2O2 are able to induce vasodilation [137]. 
Neurotransmitters 
The neurotransmitters released by the nervous endings from perivascular innervation 
exert action on the different cell types of the vascular wall through the union with its 
postsynaptic receptors [39,40]. The chemical nature and/or function of the neurotransmitters 
will depend on the animal species and the degree of innervation of the artery, being especially 
relevant in small caliber vessels, as is the case of mesenteric artery (Table 1).  
Table 1. Vascular nerve regulation. Effect of different neurotransmitters released from their 
corresponding nerve endings. 
Innervation Neurotransmitter Receptor Location Effect 
Adrenergic NA α-adrenergic Endothelium 
and VSMCs 
vasoconstriction 
β-adrenergic vasodilation 
Cholinergic ACh Muscarinic M1-
M5 
Endothelium 
and VSMCs 
Vasoconstriction 
and vasodilation 
Nitrergic NO Difuses from neurons to vascular 
muscle cells 
vasodilation 
Serotoninergic Serotonin 5HT1-5HT7 Endothelium 
and VSMCs 
Vasoconstriction  
peptidergic VIP 
NPY 
CGRP 
P Substance 
VPAC 
Y1-Y5 
RAMP/CRLR 
NK1 
Endothelium 
and VSMCs 
Vaasoconstriction 
and vasodilation 
Purinergic ATP P1-P2 Endothelium 
and VSMCs 
Vasodilation 
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Sex hormones and regulation of vascular tone 
Steroid hormones have been proven to participate in regulation of a variety of 
biological processes in the organism including modulation of blood pressure. In this regard, 
clinical and epidemiological studies have shown a higher prevalence of CVD in men than in age 
matched women, especially in pre-menopause [138]. However, after menopause the incidence 
of CVD increases, therefore, cardioprotective effects have been traditionally attributed to 
estrogens, while deleterious effects have been associated to androgens. However, more 
recent studies suggest that testosterone and other androgens have protective effects on 
cardiovascular function [29,139,140]. In this regard, most epidemiological studies have shown 
a high prevalence of low testosterone levels in men with coronary heart disease, and that this 
association exists regardless of the age of the patient. Also, low testosterone levels lead to 
insulin resistance, hypertension, dyslipidemia, and visceral obesity. These findings suggest that 
androgen deficiency in males contributesorchidectimez to the development and worsening of 
CVD [141,142]. Additionally, testosterone deficiency negatively affects the thickness of the 
carotid mid layer [143], increasing the median/lumen ratio. Consistent with this finding, the 
presence of sex hormones has also been seen to prevent internal remodeling in mesenteric 
arteries [144,145]. Inflammatory factors are also negatively affected due the low testosterone 
levels by influencing mediators of the inflammatory response, which include a C-reactive 
protein high sensitivity, and increased interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) 
levels [146]. However, the exact mechanism by which testosterone deficiency results in the 
worsening of CVD remains under research. 
Male sex hormones are able to directly affect cardiovascular function through genomic 
and non-genomic actions on androgen receptors located on cell membranes, the cytosol and 
nucleus from endothelial cells, vascular smooth muscle, fibroblasts, myocytes and platelets 
[147,148]. 
In vascular tissues testosterone acts predominantly in endothelial cells and VSMCs. 
Indeed, a variety of studies have demonstrated that the key mechanism underlying the 
vasorelaxing action of testosterone is associated with the modulation of VSMCs membrane ion 
channels for Ca2+ and K+, including inactivation of voltage operated Ca2+ channels (VOCC) 
[139,149] and an activation of K+ channels [150]. Both actions lead to vasorelaxation by 
respectively diminishing [Ca2+]i and increasing hyperpolarization. In addition to the direct 
effects in testosterone on VSMCs, androgens possess the ability to alter the release and 
function of different endothelial factors that control vascular tone, including NO, ROS and 
prostanoids; since in arteries from orchidectomized rats decrease in NO release and/or 
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bioavailability, increase in oxidative stress and synthesis of vasoconstricting prostanoids has 
been reported [41,145,151–154]. 
Regarding testosterone involvement on prostanoids it has been demonstrated that sex 
hormones influence TXA2 release and function. Orchidectomy increases TXA2 by increasing 
COX-2 expression [154,155]. In addition, the vasoconstrictor response to TXA2 and the TP 
receptors density is increased in vascular smooth muscle cells [156,157]. However, the effect 
of orchidectomy on TXA2-induced contractile response depends on the vascular bed, since 
orchidectomized rats did not modify the response to the TXA2 mimetic U-46619 in mesenteric 
arteries, while it increased this response in aorta [158]. 
It is known that sex hormones influence the vascular adrenergic function [159,160] 
although the mechanism by which this modulation occurs is still not fully understood. It has 
been shown a positive correlation between androgens and sympathetic activity have been 
described in men [161], and greater vascular resistance has been recorded in men compared 
to women, the difference being attributed to alpha-adrenergic activity [162]. Ex vivo studies 
have demonstrated in rat mesenteric arteries, that orchidectomy decreases the contraction 
induced by exogenous NA, altough the vasoconstrictor response to EFS is not modified [137]. 
Together all these data suggest that modulation of the adrenergic activity is one of the 
mechanisms by which androgens can alter peripheral vascular resistances. Concerning nitrergic 
innervation, in mesenteric arteries from orchidectomized rats, have shown a decreased nNOS 
expression, although the release of neuronal NO is mantained [137], because nNOS activity is 
increased through PKC activation [163]. However, NO metabolism is higher in segments from 
orchidectomized male rats due to the increased generation of superoxide anion (O2-) and 
peroxynitrite formation [137]. The alterations in the release and function of the different 
factors above explained, toghether with the activation of cell signaling pathways that lead to 
cell proliferation [145], may account for the altered vascular structure and functions as we 
observed in five-month post orchidectomized rats. In turn, this modiffications may be 
responsible for the development of hypertension in two-year old orchidectomized rats. 
Non-pharmacological treatment of cardiovascular disseases 
The prevention and treatment of cardiovascular diseases is still under research and 
constant improvement. Nowadays alternative pharmacotherapy such as vitamins, herbal 
remedies, and other dietary supplements (e.g. vitamin E, vitamin C, β-carotene, fish oils, garlic, 
soy, coenzyme Q10, and L-arginine) are utilized simultaneously or in replacement for 
traditional medical and interventional treatment. Most of the results of clinical studies on 
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alternative therapies used in cardiovascular disorders remain controversial, and risk-versus-
benefit ratios are not well defined. However, these considerations have not deterred patients 
from trying these agents. 
The evidence regarding fish oils- ω-3 polyunsaturated fatty acids (PUFAs) such as 
eicosapentaenoic acid (EPA) and docosahexenoic acid (DHA), on cardiovascular health is very 
wide. Multiple investigations, including in vitro studies, animal experiments, observational 
studies, and clinical trials, support these claims [164–166].  
The unique three-dimensional structure and configuration of PUFAs ω-3 contributes to 
its influence on various metabolic pathways, which determine its physiological effects (Figure 
6). PUFAs ω-3 have been shown to be involved in modifying membrane structure and function, 
tissue metabolism and gene regulation. 
 
 
 
 
 
 
 
 
 
 
Figure 6. Major ω-PUFA. Major ω-PUFA include ALA, EPA, and DHA.The long hydrocarbon 
backbones, multiple double bonds, and location of the first double bond in the (n-3) position 
result in complex and unique 3-dimensional configurations that contribute to the singular 
biologic properties of these fatty acids. Reproduced from Mozzafarian et al. [167]. 
 
Generally, in humans and mammals, the biosynthesis of EPA and DHA from α-linolenic 
acid (ALA) is a process of low metabolic efficiency in the adult. From a nutritional point of view 
linoleic acid (LA) and ALA are commonly regarded as "essential" fatty acids, since they are not 
synthesized in the human body and are mainly obtained from external sources, like plants, for 
ALA, or marine foods for EPA and DHA. Its biosynthesis is a long process; ALA penetrates cells 
through cytoplasmic-specific fatty acid carriers and by acyl-CoA synthase is converted to 
thioesters, which undergo reactions of β-oxidation, elongation and desaturation, for the 
formation of EPA (20 carbons) and DHA (22 carbons), the conversion of ALA to EPA being less 
than 5% and in ALA to DHA being less than 1% [168]. This conversion is mainly performed in 
the liver, although it occurs to a lesser extent in the glial cells, testes, cardiomyocytes and 
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mammary gland [169]. The precursor of PUFA ω-6 is the LA, whose long chain fatty acid 
derivative is arachidonic acid (20 carbons), precursor of eicosanoids, such as prostanoids, 
which as mentioned above have pro-inflammatory and pro-thrombotic properties. ALA and LA 
compete in the same enzymatic pathway that leads to the generation of their long-chain fatty 
acids. Therefore, PUFAs concentration on tissues depend to a great extent on the amount of 
their respective precursors. Ingestion of fish or fish oil provides PUFA ω-3 directly, thus 
avoiding competition for enzymes in the conversion pathway [170]. 
Ω-3 PUFAs are responsible for the reduction of atherosclerotic lesions, a decrease in 
the frequency of cardiac arrest and a reduction in overall mortality in patients at risk for 
cardiovascular disease [155]. The beneficial effects on cardiovascular health attributed to 
PUFAs ω-3 are the result of their effects on the positive modification of the lipid profile, 
reduction of blood pressure, reduction of platelet aggregation and reduction of the incidence 
of arrhythmias, in addition to their anti-inflammatory and antioxidant effects. The American 
Heart Association recommends that patients with ischemic heart disease consume 
approximately 1 g/day of EPA + DHA and, in the absence of this disease, fish oil should be 
consumed at least 2 times a week. In the recommendations of the European Society of 
Cardiology for the treatment of acute myocardial infarction, supplementation with 1 g of ω-3 
fatty acids was classified as a class I recommendation. Daily intake of ω-3 fatty acids 
recommended by the Spanish Society of Community Nutrition is 2.2 g (2 g ALA + 0.2 DHA).  
As described above, diets enriched with fish oils with high content of DHA and EPA 
have multiple protective effects against CVD. On the other hand, it has been shown that 
vascular dysfunction is the first step towards CVD development and the relevance of sex 
hormones in maintenance of vascular function and structure in men has been established. 
Based on these data, it was hypothesized that a DHA-supplemented diet could prevent or 
ameliorate the vascular changes induced when an impaired gonadal function exists. 
Taking into account the higher incidence of cardiovascular pathologies related to low 
testosterone levels such as hypogonadism, in prostate carcinomas whose treatment is based 
on the blockage of androgenic function, or the physiological process of aging itself coupled 
with an increased life expectancy with a consequent rise in aged population it is interesting to 
analyze the possible altered mechanisms involved in the regulation of vascular tone in absence 
of sex hormones in order to propose appropriate therapeutic treatments. Additionally, this 
study is of pathophysiological relevance since the results may provide evidence of the 
mechanisms involved in the protection of vascular function of the aorta (an elastic vessel) and 
the mesenteric artery (a resistant vessel), whose alterations lead to different cardiovascular 
diseases.  
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Objectives 
The aim of this study was to analyze the effects of a DHA-supplemented diet in 
orchidectomized rats on different important parameters that contribute to the maintenance of 
vascular function, such as (1) lipid profile, (2) COPs, (3) redox status, (4) and inflammatory 
factors. In addition, responses to specific stimuli in isolated conductance and resistance 
vascular beds were also studied. 
The first publication analyzed whether DHA supplemented diet affects the blood 
pressure, the lipid profile and redox status of serum samples from control and 
orchidectomized rats. The production of NO, prostanoids and the redox status (superoxide 
anion, hydrogen peroxide and the antioxidant capacity) were determined in aortic wall. 
Additionally, the endothelium dependent vasodilator response and the contribution of NO, 
prostanoids and hyperpolarizing factors on it were also investigated. 
Since mesenteric vascular bed importantly regulates the systemic blood pressure, the 
second publication was aimed to analyze the influence of DHA in the prevention of functional 
alterations in the vascular function by monitoring more specifically the basal production of NO, 
prostanoids and ROS (superoxide anion). Regarding experiments on vascular function, the 
endothelium dependent vasodilator response, as well as the involvement of prostanoids and 
NO in that response were studied. Also, the vasoconstrictor responses induced by electrical 
field stimulation, and the vasomotor effect of the neurotransmitters NA and NO were 
analyzed. 
Finally, the effect of the DHA supplemented diet on the formation of oxysterols in 
vascular wall of aorta and mesenteric arteries was collected in the third publication. The 
content of cholesterol oxidation products in vascular tissues was discussed in relation to the 
factors involved in aortic and mesenteric vascular regulation. 
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Abstract 
Benefits of n-3 polyunsaturated fatty acids (PUFAs) against cardiovascular diseases 
have been reported. Vascular tone regulation is largely mediated by endothelial factors whose 
release is modulated by sex hormones. Since the incidence of cardiovascular pathologies has 
been correlated with decreased levels of sex hormones, the aim of this study was to analyze 
whether a diet supplemented with the specific PUFA docosahexaenoic acid (DHA) could 
prevent vascular changes induced by an impaired gonadal function. For this purpose, control 
and orchidectomized rats were fed with a standard diet supplemented with 5% (w/w) 
sunflower oil or with 3% (w/w) sunflower oil plus 2% (w/w) DHA. The lipid profile, the blood 
pressure, the production of prostanoids and nitric oxide (NO), and the redox status of 
biological samples from control and orchidectomized rats, fed control or DHA-supplemented 
diet, were analyzed. The vasodilator response and the contribution of NO, prostanoids and 
hyperpolarizing mechanisms were also studied. The results showed that orchidectomy 
negatively affected the lipid profile, increased the production of prostanoids and reactive 
oxygen species (ROS), and decreased NO production and the antioxidant capacity, as well as 
the participation of hyperpolarizing mechanisms in the vasodilator responses. The DHA 
supplemented diet of the orchidectomized rats decreased the release of prostanoids and ROS, 
while increasing NO production and the antioxidant capacity, and it also improved the lipid 
profile. Additionally, it restored the participation of hyperpolarizing mechanisms by activating 
potassium. Since the modifications induced by the DHA-supplemented diet were observed in 
the orchidectomized, but not in the healthy group, DHA seems to exert cardioprotective 
effects in physiopathological situations in which vascular dysfunction exists.  
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Introduction  
The endothelium plays a pivotal role in the regulation of vascular tone through the 
release of vasoactive factors such as nitric oxide (NO), prostanoids, reactive oxygen species 
(ROS) and hyperpolarizing factors [1]. It is well known that NO-induced vasodilation is 
mediated through the activation of soluble guanylate cyclase, by increasing levels of cyclic 
guanosin monophosphate (cGMP) and cGMP-dependent protein kinase activity in the vascular 
smooth muscle of the arterial wall [2,3]. However, vascular functionality of endothelial NO 
depends on its bioavailability as NO can be metabolized into different ROS.  
Prostanoids are synthesized from arachidonic acid metabolism through the 
cyclooxygenase (COX) pathway. Apart from their involvement in platelet aggregation and 
inflammation, they are also important regulators of vascular tone in health and disease [1,4]. 
Hyperpolarizing factors and mechanisms also participate in the regulation of vessel tone by 
activating potassium channels, which are responsible for the control of membrane potential 
[2,5]. Calcium-dependent (KCa) and ATP-dependent (KATP) potassium channels are widely 
expressed in vascular tissue [6,7]. The release of an endothelium-derived hyperpolarizing 
factor (EDHF) has been proposed and while the nature of EDHF remains to be defined, studies 
have suggested that hyperpolarization may result from endothelial release of different 
substances such as NO [8], superoxide anion [9] and other ROS [10].  
Altered production and/or vascular effects of those factors could induce vascular 
dysfunction, leading to the development of different cardiovascular disorders such as 
atherosclerosis, hypertension and ischemia [1,11]. Over the years, different pharmacological 
treatments have been developed to mitigate the effects of these alterations such as 
antihypertensives, β-blockers, statins and aspirin [12–14]. Recently, studies have focused on 
nutritional interventions, with particular interest being paid to n-3 polyunsaturated fatty acids 
(PUFAs). For example, eicosapentaenoic acid (20:5n-3) or docosahexaenoic acid (DHA; 22:6n-
3), that are found in seafood and fish oil supplements, due to their beneficial effects on 
cardiovascular diseases [15]. Antithrombotic, anti-inflammatory, and vasoprotector effects of 
PUFAs on the cardiovascular system have been reported [16–18]. Additionally, hyperpolarizing 
effects of PUFAs, contributing to the vasorelaxation through the activation of potassium 
channels have also been observed [19]. Nevertheless, controversy exists as not all studies 
provide a clear and conclusive idea regarding the benefits of PUFAs against cardiovascular 
diseases [20].  
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On the other hand, it is well established that sex hormones regulate vascular function 
by altering the release and cell signaling pathways of endothelial factors that could lead to 
vascular dysfunction. In this regard, we have demonstrated that the loss of gonadal function 
modifies the production of vasoconstrictor prostanoids [21–24], superoxide anion [25–27] and 
NO [28]. Since the number of vascular pathologies matching with decreased levels of sex 
hormones is increasing [29,30], it would be of interest investigate whether a DHA-
supplemented diet could prevent vascular changes induced when an impaired gonadal 
function exists (i.e.: aging, hypogonadism, and pharmacological treatment of prostate cancer). 
Therefore, the objective of this work is to analyze how a DHA-supplemented diet affects the 
lipid profile, the blood pressure, the production of prostanoids and NO, and the redox status of 
biological samples from control and orchidectomized rats. The vasodilator response and the 
contribution of NO, prostanoids and hyperpolarizing factors were also analyzed. 
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Materials and Methods 
Animals, diets and experimental groups 
The protocol was approved by the Animal Ethics Committee of the Universidad 
Autónoma de Madrid (Ref. CEI-37-829) and procedures were performed according to the 
European Union directives 63/2010UE and Spanish regulation RD 53/2013. Male Sprague-
Dawley rats (4 months old) were housed in the Animal Facility of the Universidad Autónoma de 
Madrid (Registration number ES-20079-0000097) under 12 hour light/dark cycles and standard 
feeding with fodder and water ad libitum. After 1 week of adaptation animals were fed a 
maintenance diet for rodents (Global Diet 2014, Harlan Laboratories Inc. Indianapolis, Indiana, 
USA) supplemented with fat (5%). The controls-diet groups were supplemented with sunflower 
oil (5%) and the DHA groups with 4.5% Marinol C-38 (lipid Nutrition) and adjusted to 5% with 
sunflower oil. Nutrient content and energy distribution of each diet is summarized in Table 1. 
After 2 weeks on the control- or DHA-diet, animals were divided into two subgroups: control 
(C) and orchidectomized (ORX) male rats. Male sex hormone deprivation was induced by 
orchidectomy at 18 weeks of age under anesthesia by isofluorane inhalation. Rats were 
treated with 0.30 mg/kg meloxicam SC (Metacam 5 mg/mL; Boehringer-Ingelhelm) 
immediately after surgery and with 50 mg/kg ibuprofen, via oral administration for 4 days. 
Animals were maintained on experimental diets for six more weeks. At the end of the 
treatment, rats were sacrificed (6 months old) by CO2 inhalation and decapitation. The 
observation of seminal vesicles atrophy confirmed successful surgery. The aorta was carefully 
dissected out, cleaned of connective tissue and placed in Krebs-Henseleit solution (KHS) 
(containing, in mM: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 
11.1, Na2 EDTA 0.03) at 4°C. The investigation conforms to the Guide for the Care and Use of 
Laboratory Animals published by the USA National Institutes of Health (NIH publication No. 
85.23 revised 1985). This study was approved by the Ethical Committee of the Universidad 
Autónoma de Madrid. 
Table 1. Nutrient and energy content of experimental diets. 
 Control Diet  DHA Diet  
Carbohydrates (g/100g) 59.84 59.84 
Protein (g/100g) 14.39 14.39 
Total Fat (g/100g) 9.19 9.19 
DHA + EPA  2.01 
Energy (kcal/100g) 271.78 271.78 
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Blood pressure measurement 
Systolic blood pressure was indirectly measured in awake animals by the tail-cuff 
method [23,24] before and after the treatment using a Letica Digital Pressure Meter LE5000 
(Barcelona, Spain). 
Blood biochemical analysis 
Triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, glucose and 
creatinine in plasma were determined using an automated analyzer (Beckman Coulter-Former 
Olympus Diagnostics AU 5420, Nyon, Switzerland). 
Release of prostanoids 
After a stabilization period in KHS at 37°C for 30 minutes (pH 7.4), aortic rings from 
each group of rats was followed by 2 wash periods of 10 min using 0.2 mL of KHS. Once fresh 
KHS was replaced, arteries were exposed to 1 μM noradrenaline (NA) for 2 minutes and then 
to cumulative ACh concentrations (0.1 nM-10 μM) at 1-minute interval. Then, the medium was 
collected and stored at -80°C until used. Production of TXA2, PGI2, PGF2α and PGE2 induced by 
ACh, were monitored by measuring their stable metabolite TXB2, 6-keto-PGF1α, 13, 14-dihydro-
15-keto PGF2α and PGE2, respectively, using the respective enzyme immunoassay kit (Cayman 
Chemical). Results were expressed as pg prostanoid/mg tissue. 
Production of nitric oxide 
The fluorescent probe 4,5-diaminofluorescein was used to specifically evaluate NO 
production, as previously reported [25,26]. Briefly, aortic segments from each group of rats 
were cryoprotected with 30% w/v sucrose in PBS, frozen and stored at -80°C. After a washing 
period with PBS, the artery segments were opened to uncover the artery lumen to allow a 
better penetrance of the probe. Then the segments were immersed in N-(2-hydroxyethyl) 
piperazine-N0 2-ethane-sulfonic acid (HEPES) buffer (in mM: NaCl 119, HEPES 20, CaCl2 1.2, KCl 
4.6, KH2PO40.4, MgSO4 1, NaHCO3 5, glucose 5.5, Na2H2PO4 0.15; pH 7.4) containing 4,5-
diaminofluorescein (0.5 μM), and incubated in a light-protected, humidified chamber at 37°C 
for 45 min. Then, the segments were mounted on glad slides and imaged on a confocal 
microscope. Images were obtained with a LEICA (TCS ST2 DM IRE2) laser scanning confocal 
microscope (excitation 495 nm, emission 515 nm). Laser and image settings were unchanged 
for the acquisition of images from the three groups of rats. The photomicrographs show the 
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intensity and location of 4,5-diaminofluorescein, which reflects NO production, so that 
comparison of these groups could be made. To analyze fluorescence intensity the ImageJ 
Analysis Software (National Institutes of Health) was used. Although DAF-2 is widely used as 
detector for NO, it can also react with intermediate products of the oxidation of NO. 
Therefore, in previous studies, experiments were performed in the presence of the NO 
synthesis inhibitor L-NAME, in which the fluorescence was abolished [26,31]. The amount of 
NO released was expressed as arbitrary units. 
The basal production of NO was also measured by using a nitrite colorimetric assay kit 
(Cayman Chemical). Briefly, after a stabilization period in KHS at 37°C for 30 minutes (pH 7.4), 
aortic rings from each group of rats was followed by 2 wash periods of 10 min using 0.2 mL of 
KHS. Then, the medium was collected and stored at -80°C until assay performed. The assay was 
carried out according to the manufacturer’s protocol and the absorbance was measured at 540 
nm. Data were expressed as relative levels to control rats fed control-diet (= 1). 
Detection of superoxide anion 
Hydroethidine, an oxidative fluorescent probe, was used to evaluate superoxide anion 
levels in situ, as previously described [25,27]. Aortic segments from the four groups were 
cryoprotected with 30% (w/v) sucrose in PBS, frozen and stored at -80°C. After a washing 
period with PBS, the artery segments were opened to uncover the artery lumen to allow a 
better penetrance of the probe. Then the segments were immersed in HEPES buffer containing 
hydroethidine (5 μM), and incubated in a light-protected, humidified chamber at 37°C for 30 
min. Segments were mounted on glad slides and imaged on a confocal microscope. Images 
were obtained with a LEICA (TCS ST2 DM IRE2) laser scanning confocal microscope (excitation 
488 nm, emission 610 nm). Laser and image settings were unchanged for the acquisition of 
images from the three groups of rats. The photomicrographs show the intensity and location 
of hydroethidine, which reflects superoxide production, so that comparison of these groups 
could be made. To analyze fluorescence intensity the ImageJ Analysis Software (National 
Institutes of Health) was used. In a previous study, we reported that the fluorescence emitted 
by HE came from superoxide production since the fluorescence diminished in vessels 
pretreated with tempol, a membrane- permeable of SOD [25]. The amount of superoxide 
formation was expressed as arbitrary units. 
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Detection of hydrogen peroxide 
Hydrogen peroxide levels in serum samples and aortic rings were measured by using a 
fluorescence H2O2 assay kit (Cayman Chemical). Serum samples from each group of rats were 
collected upon the day of sacrifice and, frozen at -80°C and used directly to perform the assay. 
Frozen samples of aortic segments were homogenized at 4°C in RIPA buffer containing 50 mM 
Tris-HCl (pH 8), 150 mM NaCl, 1% (w/v) deoxycholic acid, 1% (v/v) NP-40, 1% (v/v) SDS, 100 
mM NaF, 1 mM Na3VO4, and a protease inhibitor cocktail (Calbiochem) supplemented with 
freshly prepared 1 mM phenylmethylsulfonyl fluoride. Samples were centrifuged at 16,000 g 
during 30 min at 4°C and the supernatant was collected and used to the assay, which was 
carried out according to the manufacturer’s instructions. The fluorescence at 530 and 590 nm 
excitation and emission wavelengths, respectively, was registered in a 96-microplate reader 
(Multiskan Ascent, Labsystems). Some assays were performed in the presence of catalase, an 
H2O2 scavenger, to ensure the specificity of the method. Supernatants were also used to 
quantify protein concentration by the bicinchoninic acid assay using the BCATM Protein Assay 
Kit (Pierce). Data were expressed as μmol/μg protein for serum samples and nmol/mg protein 
for aortic tissue. 
Detection of oxygen radical scavenging capacity (ORAC) 
The antioxidant activity in serum samples and in aortic vascular wall was analyzed by 
using the hydrophilic oxygen radical scavenging capacity (ORAC) assay, as previously reported 
[32]. The sample processing was identical to that explained in the preceding section. The assay 
was carried out according to the manufacturer’s instructions and the fluorescence read at 485 
and 528 nm excitation and emission wavelengths, respectively (Multiskan Ascent, Labsystems). 
Data were expressed as values relative to control rats fed control-diet.  
Vascular reactivity 
The method used for isometric tension recording has been previously described 
[21,27,33]. In summary, aortic segments were suspended in an organ bath containing 5 mL of 
KHS at 37°C, continuously bubbled with 95% O2−5% CO2 mixtures (pH 7.4). Two parallel 
stainless steel pins were introduced through the lumen of the vascular segment: one fixed to 
the bath wall and the other connected to a force transducer (Grass FTO3C; Grass Instruments 
Co., Quincy, MA, USA); this in turn was connected to a model 7D Grass polygraph. The 
segments were subjected to a tension of 1 g which was re-adjusted every 15 min during a 90 
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min equilibration period before drug administration. After this, the vessels were exposed to 
KCl (75 mM) to check the functional integrity. After a washout period the viability of vascular 
endothelium was tested by the ability of 10 μMACh to relax precontracted segments with 0.1 
μMNA.  
Concentration-response curves to ACh (0.1 nM-10 μM) and to the nitric oxide donor 
sodium nitroprusside (SNP, 0.1 nM-10 μM) were performed in NA (0.1 μM) precontracted 
aortic rings from of the four groups of rats. To analyze the participation of NO and COX-
derivatives on the response induced by ACh, the NO synthase inhibitor L-NAME (0.1 mM) and 
the nonselective inhibitor of COX-1/2, indomethacin (Indo, 10 μM), were added to the bath 30 
minutes before performing the curve. To analyze the participation of hyperpolarizing factors 
on the responses to SNP and ACh, arteries were precontracted with 30 mM KCl, to block 
membrane hyperpolarization. To analyze the function of the KCa and KATP channels, 
concentration-response curves to the KCa and KATP channel openers NS1619 (0.1 nM-10 μM) 
and pinacidil (0.1 nM-10 μM) respectively, were also performed in NA (0.1 μM) precontracted 
aortic rings from each group of rats. 
Reagents 
Drugs used were: DAF-2, HE, L-NA hydrochloride, ACh chloride, L-NAME hydrochloride, 
indomethacin, potassium chloride, SNP, NS1619 and pinacidil (Sigma-Aldrich). Stock solutions 
(10 mM) of drugs were prepared in distilled water, except for NA which was dissolved in NaCl 
(0.9%)-ascorbic acid (0.01% w/v) solution, indomethacin in 1.5 mM NaHCO3 and NS- 1619 in 
dimethylsulfoxide. These solutions were kept at -20°C and appropriate dilutions were made in 
KHS on the day of the experiment. 
Statistical analysis 
Results are given as mean ± SEM (Standard Error of the Mean). The relaxation induced 
by ACh or SNP was expressed as a percentage of initial contraction elicited by NA. Statistical 
analysis was performed by comparing the curve obtained in the presence of the different 
substances with the control curve by means of two-way analysis of variance (ANOVA). For 
blood pressure, body weight, biochemical parameters, prostanoids, NO, superoxide, hydrogen 
peroxide production and ORAC, statistical analysis was done using Student’s t-test for unpaired 
experiments. A p value of less than 0.05 was considered significant.  
Effect of dietary docosahexaenoic acid supplementation on the participation of vasodilator factors in 
aorta from orchidectomized rats 
39 
 
Results 
Animal weight, systolic blood pressure and biochemical parameters 
Before DHA administration, body weight and blood pressure were evaluated in the 
four groups of animals, showing no statistically significant differences among the groups (Table 
2). After six weeks under the experimental diet, no significant changes in blood pressure were 
found. All animals had increased in body weight to a similar extent (Table 2). As shown in Table 
3, orchidectomy induced a significant increase in total cholesterol concentrations and LDL 
cholesterol, although HDL cholesterol was not statistically modified. Triglyceride 
concentrations were also increased by the orchidectomy. The DHA-supplemented diet to the 
orchidectomized rats decreased the total cholesterol, LDL cholesterol and triglyceride levels. 
However, the control rats fed the DHA-diet decreased only the total cholesterol concentration. 
No differences were observed in serum concentration of glucose among groups. 
Table 2. Systolic blood pressure (mmHg) and body weight (g) in control (C) and 
orchidectomized (ORX) rats fed with a control or DHA-supplemented diet. 
 Blood pressure (mm Hg) Body weight (g) 
Animal group Before diet After diet Before diet After diet 
C Control (9) 149.6 + 3 148.2 + 3 390.9 + 10 502.4 + 20 
C DHA (7) 145.4 + 4 142.4 + 6 394.9 + 7 484.9 + 12 
ORX Control (8) 150.2 + 2 146.4 + 5 385.4 + 8 477.5 + 18 
ORX DHA (11) 146.6 + 3 143.5 + 1 411.6 + 10 506.5 + 9 
Values are means + SEMs. The number of animals used is indicated in parenthesis. 
 
Table 3. Serum lipid profile and glucose concentration in control (C) and orchidectomized 
(ORX) rats fed with a control or DHA-supplemented diet. 
Serum biomarkers 
(mg/dL) 
C Control C DHA ORX Control ORX DHA 
Cholesterol 121.4 ± 5.55 89.0 ± 14.57a 153.6 ± 6.49a 91.25 ± 6.42b 
HDL Cholesterol 68.25 ± 4.29 59.28 ± 6.63 78 ± 4.68 70.2 ± 5.85 
LDL Cholesterol 33.15 ± 3.12 26.13 ± 5.07 49.92 ± 3.9a 24.18 ± 2.73b 
Triglycerides 99.20 ± 5.74 80.33 ± 18.89 141.8 ± 9.63a 83.60 ± 6.8b 
Glucose 121.2 ± 12.85 150.3 ± 8.5 127.0 ± 8.4 113.0 ± 20.81 
Values are mean ± SEMs. Number of animals per group, n = 5. 
a Indicates difference with C Control group values.  
b Indicates differences with the ORX group values. 
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Release of prostanoids 
Orchidectomy increased the ACh-stimulated aortic production of TXA2, PGI2, PGF2α and 
PGE2 and PGE2 (Fig 1). These values were restored to similar levels found in aorta from control 
animals after dietary DHA supplementation. In contrast, the DHA-diet in control rats decreased 
PGE2 release and did not significantly modify the release of TXA2, PGI2, PGF2α (Fig 1). 
 
Fig 1. Effect of orchidectomy and a DHA-supplemented diet on basal release of prostanoids 
from rat aorta. Release of thromboxane B2 (TXB2), prostaglandin E2 (PGE2), PGI2 and PGF2α in 
aortas from control (C) and orchidectomized (ORX) rats fed with a control or with a DHA-
supplemented diet. Values are means ± SEMs. Number of animals, n = 5. *P < 0.01 compared 
with C rats fed Control diet; +P < 0.01 compared with ORX rats fed DHA-diet. 
Production of nitric oxide 
After incubation with 4,5-diaminofluorescein, the fluorescence emitted was decreased 
in arteries from orchidectomized rats respect to arteries from control rats, and it was 
recovered after DHA-supplemented diet to orchidectomized rats; however, the DHA-diet did 
not modify the fluorescence emitted in arteries from control rats (Fig 2A). Relative basal 
measurement of nitrite levels shown similar results (arteries from control rats-control diet: 1; 
orchidectomized rats-control diet: 0.14 ± 0.06, p < 0.05 vs control diet; control rats-DHA diet: 
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0.98 ± 0.3, p > 0.05 vs control diet; orchidectomized rats-DHA diet: 0.77 ± 0.15, p < 0.005 vs 
control diet; n = 5). 
Fig 2. Effect of orchidectomy and the DHA-supplemented diet on the production of 
endothelial NO and superoxide anion from rat aorta. Confocal micrographs showing in situ 
detection of NO (A) or superoxide anion (B) in aortic segments from control (C) and 
orchidectomized (ORX) rats fed with a control diet or with a DHA-supplemented diet (DHA). 
The sections shown are typical preparations from five rats. Quantitative analysis of 
fluorescence is also shown. Values are means ± SEMs. Number of animals, n = 5. *P < 0.01 
compared with control animals; +P < 0.01 compared with ORX rats control diet 
Detection of superoxide anion 
After incubation with hydroethidine, the arteries from orchidectomized rats showed a 
markedly higher level of fluorescence than the arteries from control rats. This increase was 
reduced in the vessels from orchidectomized rats fed with the DHA-supplemented diet. In 
contrast, the DHA diet did not affect the production of superoxide anion in control animals (Fig 
2B). 
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Detection of hydrogen peroxide 
The levels of hydrogen peroxide, in serum samples and aortic wall, were increased in 
orchidectomized rats, which were returned to control level when orchidectomized rats fed 
with the DHA-supplemented diet. The DHA-diet to control animals did not modify hydrogen 
peroxide levels (Fig 3). 
Fig 3. Effect of orchidectomy and the DHA-supplemented diet in the H2O2 content in rat 
serum and aorta. Relative levels of H2O2 in serum and aortic rings from control (C) and 
orchidectomized (ORX) rats fed with a control or with a DHA-supplemented diet. Values are 
means ± SEMs. Number of animals, n = 4. *P < 0.01 compared with control animals; +P < 0.01 
compared with ORX rats control diet. 
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Antioxidant activity 
The antioxidant activity in both serum and aortic wall was decreased by the 
orchidectomy. DHA-diet to orchidectomized rats restored the activity up to levels similar 
shown in the control rats. However, the DHA-diet failed to modify the antioxidant activity in 
the serum from control animals, and surprisingly decreased the activity level in the aortic 
vascular wall (Fig 4).  
 
Fig 4. Effect of orchidectomy and the DHA-supplemented diet in the antioxidant activity from 
rat serum and aorta. Relative levels of H2O2 in serum and aortic rings from control (C) and 
orchidectomized (ORX) rats fed with a control or with a DHA-supplemented diet. Values are 
means ± SEMs. Number of animals, n = 6. *P < 0.01 compared with control animals; +P < 0.01 
compared with ORX rats control diet. 
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Vascular reactivity  
The vasodilator response induced by ACh (0.1 nM-10 μM) in aortic segments 
precontracted with NA (0.1μM) was similar in the four groups of rats (Fig 5). The vasodilator 
response induced by the NO donor SNP was not modified in any group (Fig 5), indicating that 
the sensitivity of NO on smooth muscle was intact. 
Fig 5. Effect of orchidectomy and a DHA-supplemented diet on the concentration-response 
curves to acetylcholine and sodium nitroprusside in rat aorta. Concentration-response curves 
to acetylcholine and sodium nitroprusside in aortic segments from control (C) and 
orchidectomized (ORX) rats fed with a control or a DHA-supplemented diet. Results (means ± 
SEMs) are expressed as percentage of inhibition of the contraction induced by 0.1 μM 
noradrenaline. Number of animals, n = 5–8. 
To investigate the contribution of NO or prostanoids on the vasodilator response 
induced by ACh, the effect of the inhibitors of NO or prostanoids synthesis, L-NAME or 
indomethacin, was examined. In the presence of L-NAME the ACh-induced relaxation was 
inhibited in aortic segments from control or orchidectomized rats; the control-diet did not 
alter the inhibitory effect of L-NAME, while in segments from orchidectomized rats 
supplemented with DHA a small relaxation occurred (Fig 6). Incubation with indomethacin 
decreased the ACh-induced relaxation response in arteries from control rats fed control diet, 
while it did increase the ACh-induced response when the animals were fed DHA-diet. In aortas 
from orchidectomized rats fed control- or DHA-diet, indomethacin did not modify the Ach-
induced response (Fig 6). 
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Fig 6. Orchidectomy and DHA-supplemented diet modulate the participation of different 
factors in the Ach-induced responses. Effect of L-NAME (0.1 mM) or indomethacin (Indo, 10 
μM) on the concentration response curves to acetylcholine in the NA-precontracted aortic 
segment from control (C) and orchidectomized (ORX) rats fed with a control diet or with a 
DHA-supplemented diet (DHA diet). The effect of precontracting vessels with KCl (30 mM) is 
also represented. Results (means ± SEMs) are expressed as percentage of inhibition of the 
contraction induced by 0.1 μM NA or 30 mM KCl. Number of animals, n = 5–8. 
The possible participation of hyperpolarizing mechanisms in the ACh-induced response 
was also analyzed by precontracting vessels with KCl (30 mM) that blocks the membrane 
hyperpolarization. Under this condition the ACh-induced response was decreased in arteries 
from the four groups of animals (Fig 6), but in a greater extent in aortas from orchidectomized 
animals fed with a DHA supplemented diet.  
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Since NO can also hyperpolarize the membrane of smooth muscle cell, the 
participation of hyperpolarizing mechanisms on the relaxation induced by SNP was also 
analyzed. In KCl-precontracted arteries the relaxation induced by SNP was reduced in the four 
groups of animals (Fig 7). 
 
Fig 7. Orchidectomy and DHA-supplemented diet modulate the involvement of 
hyperpolarizing mechanisms in the sodium nitroprusside-induced response. Concentration-
response curves to sodium nitroprusside in NA- or KCl-precontracted aortic segments from 
control (C) and orchidectomized (ORX) rats fed with a control diet or with a DHA-
supplemented diet (DHA diet). Results (means ± SEMs) are expressed as percentage of 
inhibition of the contraction induced by 0.1 μM NA or 30 mM KCl. Number of animals, n = 4–7. 
The SNP-induced relaxation was decreased in a greater extent in arteries from control 
rats than in those from orchidectomized rats. The DHA-diet did not significantly modify the 
response in arteries from control rats, while it increased the blockage in arteries from 
orchidectomized (Fig 7). 
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Since the activation of the KCa and KATP channels causes vasodilation by hyperpolarizing 
cell membrane, the effects of orchidectomy and DHA supplementation on the function of the 
KCa and KATP channels were analyzed. Concentration-response curves to the KCa and KATP 
channels openers NS1619 (0.1 nM-10 μM) and pinacidil (0.1 μM-10 μM), respectively, were 
analyzed in NA (0.1 μM) precontracted aortic rings from the four groups of rats (Fig 8). 
Orchidectomy partially decreased the vasodilator response induced by NS1619, which was 
recovered in the orchidectomized DHA group. Orchidectomy decreased the pinacidil-induced 
response, which was also recovered after DHA-supplemented diet. However, the DHA-diet 
failed to modify the NS1619- and pinacidil-induced responses in arteries from control rats (Fig 
8). 
 
Fig 8. Effect of orchidectomy and the DHA-supplemented diet on the function of KCa and KATP 
channels. Concentration-response curves to the KCa and KATP channels openers NS1619 and 
pinacidil in NA-precontracted aortic segments from control (C) and orchidectomized (ORX) rats 
fed with a control diet or with a DHA-supplemented diet (DHA). Results (means ± SEMs) are 
expressed as percentage of inhibition of the contraction induced by 0.1 μM NA. Number of 
animals, n = 4–6. 
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Discussion 
The present work provides information on the different impact of a DHA-
supplemented diet to healthy or orchidectomized rats, analyzing the possible modifications in 
the lipid profile, in the release of different vascular factors and in the redox status that control 
vascular function. The interest of this particular experimental model is because the number of 
vascular pathologies matching with decreased levels of sex hormones (i.e.: aging, 
hypogonadism, and pharmacological treatment of prostate cancer) is increasing [29,30]. We 
have previously demonstrated that the release of prostanoids was increased 5 months post-
orchidectomy in aorta and mesenteric arteries [21–23,25], most likely as a consequence of 
increased oxidative stress observed in these experimental conditions. In the present study we 
show that in aorta from 6 weeks post-orchidectomized rats the ACh-induced release of PGI2, 
PGF2α and PGE2 were already increased, as observed for TXA2 release in a previous study [28]. 
These results showed that the loss of gonadal function favored the onset of a pro-
inflammatory environment. Dietary supplementation with DHA prevented the increase in the 
prostanoids release induced by orchidectomy, which agrees with the described anti-
inflammatory properties of PUFAs [16,17,34]. However, in control animals, this property was 
shown for PGE2, that was decreased, which is in line with most of the studies describing a 
reduction after PUFAs-diet in healthy subjects [35,36]. The DHA-diet did not modify the 
production of TXA2, PGI2 and PGF2α in control rats, as previously reported for TXA2 production 
[37]. 
Regarding the production of NO, quantified by measuring nitrite production and the 
fluorescence emitted by DAF-2, the current study shows that it was decreased in aortas from 6 
weeks post-orchidectomized rats, according to previously published [28], while in aortas from 
orchidectomized rats fed a DHA-supplemented diet the NO production was restored. These 
results are in line with other studies describing increase in NO release by n-3 PUFA [38–40]. 
However, the DHA-diet did not significantly modify the release of NO in arteries from control 
rats, as reported by Omura and coworkers [41] who observed that although the EPA increased 
NO release, DHA had no effect. This result indicates that the effect on NO release may depend 
on the specific PUFA tested. But what is more important is that the effect of a specific PUFA, 
DHA in our study, on the prostanoids and NO release seems to depend on the baseline 
conditions of the experimental treated animals.  
Oxidative stress is one of the major detrimental events in the induction of vascular 
dysfunction. Since we already reported that 5 months post-orchidectomy increased the 
production of superoxide anion [25,26,31], we now analyzed the effect of the DHA-
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supplemented diet on the ROS production. The results showed that 6 weeks post-
orchidectomy already increased the production of superoxide in the aortic wall, while in 
arteries from orchidectomized rats fed the DHA-supplemented diet the production of 
superoxide was diminished to a level similar of that found in arteries from control rats. 
However, the aorta from control rats fed DHA-diet did not modify the production of 
superoxide. Thus, superoxide production has been decreased by n-3 PUFAs in platelets from 
diabetic hypertensive patients [42]. DHA protects endothelial cells culture against oxidative 
stress through Nrf2 activation [43] and down-regulating Nox4 [44]. These results suggest that 
DHA interfere with the oxidative stress in pathophysiological situations in which there is a ROS 
overproduction. It is important to mention that although in previous studies we reported that 
the fluorescence emitted by hydroethidine came from superoxide-derived products [25,27], 
the specificity of this probe has been questioned because it could generate artefacts [45–47]. 
Therefore, it would be desirable to use other methods in future studies. Nevertheless, since 
superoxide can be metabolized to hydrogen peroxide, which was increased in mesenteric 
arteries from orchidectomized rats [25], and that exerts important vascular effects [25, 27] we 
also analyzed the presence of this compound in serum and aortic wall. The results shown that 
orchidectomy increased the hydrogen peroxide content in both serum and aortic samples, 
which were restored by the DHA-diet. These results are in agreement with the modification in 
the superoxide anion production commented above. Here again, control rats fed DHA-diet did 
not modify the hydrogen peroxide content respect to that observed with control diet. In view 
of these results, the oxygen radical scavenging capacity in serum and aortic wall was also 
studied. As expected, orchidectomy decreased the antioxidant activity, which was recovered in 
the orchidectomized rats fed DHA-diet. DHA-diet failed to modify the antioxidant activity in 
samples from control animals. The overall results on the redox status demonstrates the 
antioxidant ability of DHA [48,49] and provides evidence for a positive effect of DHA-
supplemented diet to prevent vascular dysfunction caused by an imbalance between the 
formation and elimination of ROS.  
In addition to changes in the production of NO, prostanoids and ROS induced by 
orchidectomy, the lipid profile is also under control of the androgens levels, and importantly 
affects the vascular function. In this regard, the orchidectomized group fed the control-diet 
showed an increase in total cholesterol, LDL-cholesterol and triglycerides, according to the 
effect of androgen deprivation on lipid profile [50]. However, the DHA-diet normalized the 
lipid levels in orchidectomized rats while in control animals diminished only the total 
cholesterol level, without modifying the rest of parameters. These results are in line with 
previous human [51] and animal [52] studies showing that PUFAs intake improves the altered 
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lipid profile. Importantly, despite the changes in the production of NO, prostanoids, ROS and in 
the lipid profile in the ORX and ORX-DHA group, the systolic blood pressure was not modified 
in any group. The lack of effect of a DHA-supplemented diet on blood pressure is in agreement 
with other studies where no effects were noted in the short term [53]. However, a decrease in 
blood pressure has also been reported in both spontaneously hypertensive [54,55] and aged 
[53] rats. Additionally, our results also suggest that the alterations in vascular function 
described below are independent of hemodynamic changes.  
Regarding endothelium-dependent relaxation, it was shown that 6-weeks post-
orchidectomy did not modify the ACh-induced relaxation. The DHA-supplemented diet to 
control or orchidectomized rats did not alter the ACh-induced relaxation, which is in 
agreement with other studies in aged [53], hypertensive [55] or diabetic [56] rats. However, 
other studies have revealed that the intake of n-3 PUFAs improves the NO-mediated 
endothelium-dependent vasodilation in patients with coronary artery disease [57]. These 
results suggest that the influence of DHA on the endothelium dependent vasorelaxation is 
controversial and appears to mainly depend on the experimental conditions and the animal 
species. It is noteworthy that while the release of prostanoids and NO are modified by the 
orchidectomy and restored by the DHA-diet, the endothelial-dependent vasodilator responses 
induced by ACh remain unchanged in vessels from the four groups of rats. However, the 
contribution of different factors such as NO, prostanoids or hyperpolarizing mechanisms 
cannot be ruled out. We observed that NOS inhibition with L-NAME blocked the ACh-induced 
response in aortas from control rats with control- or DHA-diet, indicating that the vasorelaxant 
response to ACh is mainly due to the NO, as described for large elastic arteries [58]. In aortas 
from orchidectomized rats, the ACh-induced relaxation was also abolished by L-NAME, which 
coincides with the diminished production of NO reported in aorta from these animals. 
However, in aorta from orchidectomized rats fed with DHA, L-NAME did not stop the ACh-
induced response, as a very small relaxation can be observed. Considering that the sensitivity 
of the smoothmuscle to NO was not modified, these results indicate that although NO is the 
most important factor in the response to ACh, other mechanisms may be contributing to the 
relaxation in this group of vessels. Therefore, the participation of prostanoids in the ACh-
induced response were analyzed. The results showed that the inhibition of COX-1 and COX-2 
with indomethacin decreased the vasodilator action of Ach in control rats, indicating the 
involvement of vasodilator net effect of prostanoids in this response. However, in aorta from 
orchidectomized rats the ACh-induced response was not modified suggesting that the net 
vasodilator effect has been lost. This is supported by the increased production of 
vasoconstrictor prostanoids, which was discussed above. Furthermore, when prostanoid 
Effect of dietary docosahexaenoic acid supplementation on the participation of vasodilator factors in 
aorta from orchidectomized rats 
51 
 
synthesis is inhibited the formation of NO is modified [22], indicating that NO may also be 
involved.  
Despite the decreased production of prostanoids, in arteries from orchidectomized 
rats fed the DHA-diet, indomethacin did not modify the ACh-induced response, which could be 
attributed to that DHA could reduce the sensitivity of the smooth muscle to prostanoids 
[59,60]. More surprising was the effect of DHA-diet in control rats, in which an increase in the 
Ach response in presence of indomethacin was observed, indicating the prevalence of a net 
vasoconstrictor effect of prostanoids. This result may be related to the decrease in PGE2, and 
indicates that intake of DHA supplements not would have a beneficial effect on the vasodilator 
response in healthy subjects.  
Since the endothelium is able to synthesize EDHF and/or substances that hyperpolarize 
the cell membrane [8–10], the participation of hyperpolarizing mechanisms in the ACh-induced 
response was analyzed. Our results show that after blocking hyperpolarization [61], the 
response to ACh was decreased in all groups of animals, but to a greater extent in aortas from 
orchidectomized rats with DHA-supplemented diet. This suggests a participation of 
hyperpolarizing mechanisms in the relaxation induced by ACh, in particular when 
orchidectomized animals are fed a DHA-supplemented diet. These results are in agreement 
with the hyperpolarizing mechanisms induced by DHA [17]. In view of these results, the 
hyperpolarizing effect of NO was also investigated. These results indicate that NO partially 
hyperpolarizes the cell membrane and that orchidectomy decreases the degree of SNP-
induced hyperpolarization, which was restored by the DHA-diet. It is well known that KCa and 
KATP channels have an important role on vascular tone regulation [5,7] and that their function 
may be modulated by sex hormones [62–64] and PUFAs [17,65,66]. Taking into account that 
orchidectomy decreases the participation of hyperpolarizing mechanisms induced by ACh or 
SNP, the vasodilator response to the KCa and KATP channels openers NS1619 and pinacidil, 
respectively, were analyzed. We observed that orchidectomy decreased the NS1619- and 
pinacidil-induced responses, which is in line with the hyperpolarizing effects caused by the 
acute administration of testosterone [62–64]. In arteries from orchidectomized DHA-
supplemented rats, the vasodilator response elicited by the potassium channels openers was 
restored up to similar levels to those found in arteries from control rats. Therefore, the effect 
of DHA supplementation is in agreement with other studies where increased activation of KCa 
[19,65,66] and KATP [67,68] channels have been reported. However, the DHA-diet did not 
increase the activation of K channels in control to rats, pointing out that the choice of 
experimental models is crucial to determine the actions of a DHA-supplemented diet.  
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The results showed in the present study are of pathophysiological relevance since they 
provided mechanisms involved in the regulation of elastic artery function. The maintenance 
for long periods of an increased oxidative stress and chronic inflammation increase the 
proteolytic activity of the extracellular matrix, which could affect the integrity of aortic wall 
and ultimately lead to vascular damage as observed in aortic aneurysms [69]. 
In summary, the results obtained in aortas from male rats showed that orchidectomy 
induced the following effects: i) increased the production of prostanoids and ROS; ii) 
decreased NO production and the antioxidant capacity; iii) negatively affected the lipid profile; 
and iv) decreased the participation of hyperpolarizing mechanisms in the vasodilator 
responses, in which KCa and KATP channels are involved. The DHA-supplemented diet of the 
orchidectomized rats exerted anti-inflammatory and antioxidant effects by decreasing the 
release of prostanoids and ROS, while increasing NO production and the antioxidant capacity, 
and it also improved the lipid profile. Additionally, it increased the participation of 
hyperpolarizing mechanisms by activating KCa and KATP channels.  
Since the modifications induced by the DHA-supplemented diet were observed only in 
the orchidectomized but not in the healthy group, the overall results show that DHA exerts 
cardioprotective effects in physiopathological situations in which vascular dysfunction exists. 
To further explore the mechanisms of action of PUFAs in health and disease to explain these 
differences more studies will be required. 
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Abstract 
Over the past few decades, the cardiovascular benefits of a high dietary intake of long-
chain polyunsaturated fatty acids (PUFAs), like docosahexaenoic acid (DHA), have been 
extensively studied. However, many of the molecular mechanisms and effects exerted by 
PUFAs have yet to be well explained. The lack of sex hormones alters vascular tone, and we 
have described that a DHA-supplemented diet to orchidectomized rats improve vascular 
function of the aorta. Based on these data and since the mesenteric artery importantly 
controls the systemic vascular resistance, the objective of this study was to analyze the effect 
of a DHA-supplemented diet on the mesenteric vascular function from orchidectomized rats. 
For this purpose mesenteric artery segments obtained from control, orchidectomized or 
orchidectomized plus DHA-supplemented diet were utilized to analyze: (1) the release of 
prostanoids, (2) formation of NO and ROS, (3) the vasodilator response to acetylcholine (ACh), 
as well as the involvement of prostanoids and NO in this response, and (4) the vasoconstrictor 
response to electrical field stimulation (EFS), analyzing also the effect of exogenous 
noradrenaline (NA), and the NO donor, sodium nitroprusside (SNP). The results demonstrate 
beneficial effects of DHA on the vascular function in orchidectomized rats, which include a 
decrease in the prostanoids release and superoxide formation that were previously 
augmented by orchidectomy. Additionally, there was an increase in endothelial NO formation 
and the response to ACh, in which NO involvement and the participation of vasodilator 
prostanoids were increased. DHA also reversed the decrease in EFS-induced response caused 
by orchidectomy. All of these findings suggest beneficial effects of DHA on vascular function by 
reversing the neurogenic response and the endothelial dysfunction caused by orchidectomy.  
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Introduction 
The involvement of endothelial, hormonal and neural factors in the regulation of 
vascular function is well established [1, 2], although the contribution of these factors depends 
on the type of the vessel. In response to different stimuli the endothelium can release 
different factors, such as nitric oxide (NO), prostanoids, reactive oxygen species (ROS), among 
others [1]. NO is a signaling molecule formed by the enzyme nitric oxide synthase (NOS) that 
plays a crucial role in vascular homeostasis regulating the vascular tone, and therefore also 
influences blood pressure. This molecule exerts vasodilation in smooth muscle cells by 
stimulating the protein kinase G (PKG) trough soluble guanylate cyclase (sGC) in the smooth 
muscle of the arterial wall [3]. Also, NO has anti-inflammatory, antithrombotic, 
antiproliferative, and antioxidant effects. A decrease in NO synthesis and/or bioavailability 
leads to the development of vascular dysfunction [4].  
The endothelium is also a source of ROS generated through the activation of xanthine 
oxidase, cyclooxygenase, and cytochrome P-450 [5, 6]. Excessive production of ROS, causes 
vascular dysfunction by outstripping endogenous antioxidant defense mechanisms, and it has 
been implicated in the pathogenesis of many cardiovascular diseases, including 
hypercholesterolemia, atherosclerosis, hypertension, diabetes, and heart failure [7].  
The vascular tone is also regulated by prostanoids originating from arachidonic acid 
metabolism through the cyclooxygenase (COX) pathway [8]. Prostanoids are involved in 
platelet aggregation and inflammation, playing an important role in the regulation of vascular 
tone in physiopathological conditions. Vasodilator prostanoids such as prostacyclin and 
prostaglandin E2 (PGE2) play a role in parallel with NO in the regulation of vascular tone and 
blood pressure. In comparison, TXA2 is considered a potent vasoconstrictor and increased 
production of this factor is correlated with alterations in vascular functions [9].  
Rat mesenteric artery possesses nitrergic and sympathetic innervations in which the 
release of NO and noradrenaline (NA) are involved in the neuronal regulation of vascular tone 
[10±12]. Upon release, NO induces vasodilator action as commented above. NA release causes 
vasoconstrictor effect through the activation of alpha-adrenoceptors [13]. The involvement of 
sensory innervation in the regulation of vascular tone depends on gender, physiological 
situation, and even rat strain [13±15].  
In addition to the endothelial and neuronal factors, hormones also participate in the 
control of vascular function. Regarding sex hormones, cardioprotective effects have been 
reported in men and women [2, 16]. Previous studies from our group have shown that the loss 
of gonadal function in male and female rats increased the release and function of 
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vasoconstrictor prostanoids [17, 18], as well as the synthesis of ROS [13, 19, 20]. This 
accumulating production, when maintained for a significant amount of time, could lead to the 
development of cardiovascular diseases. 
On the other hand, several studies have demonstrated the cardiovascular benefits of 
n-3 polyunsaturated fatty acids (n-3 PUFAs) [21, 22]. The most prominent n-3 fatty acids with 
demonstrated cardiovascular benefits are eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), which are predominantly found in fish oils. The mechanisms by which these n-3 
PUFAs decrease endothelial dysfunction involve lipid and prostanoid metabolism, leading to 
secondary favorable effects on blood pressure and thrombosis [23]. Additionally, we have 
reported the beneficial effect of a DHA-supplemented diet of orchidectomized rats on aorta 
function [24].  
Considering all of these data and taking into account that mesenteric circulation has an 
important participation in systemic blood pressure control, it would be important to study the 
influence of PUFAs, specifically DHA, to prevent the functional alterations of mesenteric 
arteries observed after deprivation of male sex hormones. Therefore, the aim of this work was 
to study how a DHA-supplemented diet influences the mesenteric artery vascular function 
from orchidectomized rats, by monitoring: (1) the basal production of NO, ROS and 
prostanoids, (3) the vasodilator response to acetylcholine (ACh), as well as the involvement of 
prostanoids and NO in this response (4) the vasoconstrictor response to electrical field 
stimulation (EFS); additionally, the effect of exogenous NA, and the NO donor, SNP were also 
analyzed.  
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Materials and Methods 
Animals, diets and experimental groups 
The protocol was approved by the Animal Ethics Committee of the Universidad 
Autónoma de Madrid (Ref. CEI-37-829) and procedures were performed according to the 
European Union directives 63/2010UE and Spanish regulation RD 53/2013.  
Male Sprague-Dawley rats (6 months old) were obtained from the Animal Quarters of 
the Universidad Autónoma de Madrid and housed in the Animal Facility of the Universidad 
Autónoma de Madrid (Registration number ES-20079-0000097), under 12 h light/dark cycles 
and standard feeding with fodder and water ad libitum. After 1 week of adaptation animals 
were fed a maintenance diet for rodents (Global Diet 2014, Harlan Laboratories Inc. 
Indianapolis, Indiana, USA) supplemented with fat (5%). The control group was supplemented 
with sunflower oil (5%) and the DHA group with 4.5% Marinol C-38 (Lipid Nutrition) and 
adjusted to 5% with sunflower oil. Nutrient content and energy distribution of each diet is 
summarized in Table 1. After 2 weeks on the diet, animals were divided into two groups: 
control and orchidectomized males. Male sex hormone deprivation was induced by 
orchidectomy at 18 weeks of age under anesthesia by isofluorane inhalation. Rats were 
treated with 0.30 mg/Kg meloxicam SC (Metacam 5 mg/ml; Boehringer-Ingelheim) 
immediately after surgery and with 50 mg/Kg ibuprofen, via oral administration for 4 days. 
Animals were maintained under experimental diets for six more weeks. At the end of the 
treatment, rats were sacrificed by CO2 inhalation and decapitation. The observation of seminal 
vesicles atrophy confirmed successful surgery. The mesenteric artery was carefully dissected 
out, cleaned of connective tissue and placed in Krebs-Henseleit solution (KHS) (containing, in 
mM: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 11,1, Na2 EDTA 
0.03) at 4° C. 
Table 1. Nutrient and energy content of experimental diets. 
 Control Diet  DHA Diet  
Carbohydrates (g/100g) 59.84 59.84 
Protein (g/100g) 14.39 14.39 
Total Fat (g/100g) 9.19 9.19 
DHA + EPA  2.01 
Energy (kcal/100g) 271.78 271.78 
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Blood pressure measurement 
Systolic blood pressure was indirectly measured in awake animals by the tail-cuff 
method [17, 25] before and after the treatment using a Letica Digital Pressure Meter LE5000 
(Barcelona, Spain). 
Release of prostanoids 
After a stabilization period in KHS at 37° C for 30 minutes (pH 7.4), mesenteric rings 
from each group of rats was followed by 2 wash periods of 10 min using 0.2 mL of KHS. Once 
fresh KHS was replaced, after a period of 10 min and the medium was collected and stored at -
80ÊC until used. Production of TXA2, PGI2 and PGE2, were monitored by measuring their 
stable metabolite TXB2, 6-keto-PGF1α, and PGE2, respectively, using the respective enzyme 
immunoassay kit (Cayman Chemical). Results were expressed as pg prostanoid/mL per mg of 
tissue. 
Production of nitric oxide 
The fluorescent probe 4,5-diaminofluorescein was used to specifically evaluate NO 
production. Briefly, mesenteric segments from control, orchidectomized and orchidectomized 
with DHA diet groups were cryoprotected with 30% w/v sucrose in PBS, frozen and stored at -
80ÊC. After a washing period with PBS, the artery segments were opened to uncover the artery 
lumen to allow a better penetrance of the probe. Then the segments were immersed in 4- (2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (in mM: NaCl 119, HEPES 20, 
CaCl2 1.2, KCl 4.6, KH2PO4 0.4, MgSO4 1, NaHCO3 5, glucose 5.5, Na2H2PO4 0.15; pH 7.4) 
containing 4,5-diaminofluorescein (0.5 μM), and incubated in a light-protected, humidified 
chamber at 37° C for 45 min. Then, the segments were mounted on glass slides and imaged on 
a confocal microscope. Images were obtained with a LEICA (TCS ST2 DM IRE2) laser scanning 
confocal microscope (excitation 495 nm, emission 515 nm). Laser and image settings were 
unchanged for the acquisition of images from the three groups of rats. The photomicrographs 
show the intensity and location of 4,5-diaminofluorescein, which reflects NO production, so 
that comparison of these groups could be made. To analyze fluorescence intensity, the ImageJ 
Analysis Software (National Institutes of Health) was used. The amount of NO released was 
expressed as arbitrary units.  
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Detection of superoxide anion 
The fluorescent probe, hydroethidine, was used to evaluate superoxide anion levels in 
situ, as previously described [13, 26]. Mesenteric segments from the three groups were 
cryoprotected with 30% (w/v) sucrose in PBS, frozen and stored at -80° C. After a washing 
period with PBS, the artery segments were opened to uncover the artery lumen to allow for a 
better penetration of the probe. Then, the segments were immersed in HEPES buffer 
containing hydroethidine (5 μM), and incubated in a light-protected, humidified chamber at 
37° C for 30 min. Segments were mounted on glass slides and imaged on a confocal 
microscope. Images were obtained with a LEICA (TCS ST2 DM IRE2) laser scanning confocal 
microscope (excitation 488 nm, emission 610 nm). Laser and image settings were unchanged 
for the acquisition of images from the three groups of rats. The photomicrographs show the 
intensity and location of hydroethidine, which reflects superoxide production, so that 
comparison of these groups could be made. To analyze fluorescence intensity, the ImageJ 
Analysis Software (National Institutes of Health) was used. The amount of superoxide 
formation was expressed as arbitrary units.  
Vascular reactivity 
The method used for isometric tension recording has been previously described [26, 
27]. In summary, mesenteric artery segments were suspended in an organ bath containing 5 
mL of KHS at 37° C, continuously bubbled with 95% O2 -5% CO2 mixtures (pH 7.4). Two parallel 
stainless steel pins were introduced through the lumen of the vascular segment: one fixed to 
the bath wall and the other connected to a force transducer (Grass FTO3C; Grass Instruments 
Co., Quincy, MA, USA); this in turn was connected to a model 7D Grass polygraph. The activity 
was reflected in a computer through a computer program (eDAQ Software). The segments 
were subjected to a tension of 0.5 g which was re-adjusted every 15 min during a 90 min 
equilibration period before drug administration. After this, the vessels were exposed to KCl (75 
mM) to check their functional integrity. After a washout period the viability of vascular 
endothelium was tested by the ability of 10 μM ACh to relax pre-contracted segments with 0.1 
μM NA.  
To determine the participation of innervation in the regulation of vascular tone in 
mesenteric artery, frequency-response curves to EFS were performed. The parameters used 
for EFS were 200 mA, 0.3 ms, 1±16 Hz, for 30 s with an interval of 1 min between each 
stimulus, the time required to recover basal tone. Since NO neurotransmitter and NA play key 
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roles in the mesenteric artery, concentration-response curves to NA (1 nM-10 μM) and the NO 
donor, SNP (1 nM-10 μM) were performed.  
Concentration-response curves to ACh (0.1 nM-10 μM) were performed in NA (0.1 μM) 
pre-contracted mesenteric artery rings from of the three groups of rats. To analyze the 
participation of NO and prostanoids on the ACh-induced response, the NO synthase inhibitor L-
NAME (0.1 mM) or the nonselective inhibitor of COX-1/2, indomethacin (Indo, 10 μM), were 
added to the bath 30 minutes before performing the curve. 
Drugs 
Drugs used were: L-NA hydrochloride, ACh chloride, L-NAME hydrochloride, 
indomethacin, potassium chloride, SNP (Sigma-Aldrich). Stock solutions (10 mM) of drugs were 
prepared in distilled water, except for NA which was dissolved in NaCl (0.9%)-ascorbic acid 
(0.01% w/v) solution, indomethacin in 1.5 mM NaHCO3 in dimethylsulfoxide. These solutions 
were maintained at -20° C and appropriate dilutions were made in KHS on the day of the 
experiment. 
Statistical analysis 
Results are given as mean ± SEM (Standard Error of the Mean). The relaxation induced 
by ACh was expressed as a percentage of initial contraction elicited by NA. Statistical analysis 
was performed by comparing the curve obtained in the presence of the different substances 
with the control curve by means of two-way analysis of variance (ANOVA). For blood pressure, 
body weight, prostanoids, NO, and superoxide production, statistical analysis was done using 
Student's t-test for unpaired experiments. A p value of less than 0.05 was considered 
significant. 
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Results 
Animal weight and systolic blood pressure  
Pre-diet body weight and blood pressure measures from control, orchidectomized and 
orchidectomized with the DHA-supplemented diet were not significantly modified. Six weeks 
postdiet all groups increased body weight to a similar extent and blood pressure did not show 
significant changes. Results already published [24]. 
Production of nitric oxide 
The orchidectomized group showed a decrease in the fluorescence emitted by 4,5-
diaminofluorescein after incubation in the mesenteric tissue with respect to arteries from 
control rats. DHA-supplemented diet restored the fluorescence levels reduced by orchiectomy 
similarly to values found in control animals (Fig 1A). 
 
Fig 1. Effect of orchidectomy and DHA supplemented diet in endothelial production of NO 
and superoxide in rat mesenteric arteries. Confocal micrographs showing in situ detection of 
NO (A) or superoxide anion (B) in mesenteric artery segments from control (C) and 
orchidectomized (Cx) rats fed with a control diet and from Cx rats fed with a DHA-
supplemented diet (Cx DHA). The sections shown are typical preparations from five rats. 
Quantitative analysis of fluorescence is also shown. Values are means ± SEMs, n = 5, *P < 0.001 
compared with control animals; +P < 0.002 compared with Cx rats control diet.  
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Detection of superoxide anion  
HE fluorescence levels showed an increase in orchidectomized rat vessels, compared 
to the ones from control group. The DHA-supplemented diet decreased these levels on the 
orchiectomized rats (Fig 1B). 
Release of prostanoids 
Orchidectomy increased the basal release of TXB2 and PGE2 (Fig 2A and 2B). However, 
orchidectomy did not statistically modify the release of 6-keto-PGF1α (Fig 2C). DHA 
supplemented diet decreased the release of the three prostanoids analyzed (Fig 2). 
Fig 2. Effect of orchidectomy and DHA supplemented diet on prostanoid basal release in rat 
mesenteric arteries. Release of thromboxane B2 (TXB2), prostaglandin E2 (PGE2) and PGI2 
(panels A-C) in mesenteric artery from control (C) and orchidectomized (Cx) rats fed with a 
control diet and from Cx rats fed with a DHA-supplemented diet (Cx DHA). Values are means ± 
SEMs. n = 4±8; *p <0.05 compared to arteries from control group, +p <0.05 compared with 
arteries from Cx Control group. 
Vascular reactivity 
Mesenteric segments from all three groups contracted similarly to 75 mM KCl (C 
Control 1069 ± 78 mg; Cx Control 1291 ± 124 mg; Cx DHA 1199 ± 79 mg; p > 0.05). 
Orchidectomy decreased the EFS-induced contraction which was reversed by the DHA 
supplemented diet (Fig 3). The contractile response induced by exogenous NA (10 nM- 10 μM) 
was similar in vessels from all three groups of rats (Fig 4).  
The relaxation induced by SNP was analyzed in segments previously pre-contracted 
with NA (1 μM). Orchidectomy significantly increased the vasodilator response in segments 
from orchidectomized rats (ANOVA, p < 0.001, Fig 5). This response was not modified by DHA 
supplemented diet (Fig 5). 
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Fig 3. Effect of orchidectomy and DHA supplemented diet in the EFS-induced response in rat 
mesenteric arteries. Effect of EFS contractile response in mesenteric artery segments of male 
rats from control rats with control diet (A), orchidectomized rats with control diet (B) and 
orchidectomized rats with DHAsupplemented diet (C). Results (mean ± SEM) are expressed as 
percentage of contraction elicited by 75 mM KCl. Number of animals indicated in parenthesis  
 
Fig 4. Effect of orchidectomy and DHA supplemented diet in the contractile response to NA 
curves in rat mesenteric arteries. Noradrenaline contractile response in mesenteric artery 
segments from control rats with control diet (A), orchidectomized rats with control diet (B) and 
orchidectomized rats with DHA-supplemented diet (C). Results (mean ± SEM) expressed as 
percentage of contraction elicited by 75 mM KCl. Number of animals indicated in parenthesis. 
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Fig 5. Effect of orchidectomy and DHA supplemented diet in the vasodilator response to SNP 
curves in rat mesenteric arteries. Orchidectomy and DHA supplemented diet influence on the 
vasodilator response to sodium nitroprusside in mesenteric artery segments of male rats, in 
control rats with control diet (A), orchidectomized rats with control diet (B) and 
orchidectomized rats with DHA-supplemented diet (C). Results (mean ± SEM) are expressed as 
percentage of inhibition of precontraction elicited by 1 μM noradrenaline. Number of animals 
indicated in parenthesis. 
The vasodilator response induced by ACh (0.1 nMÐ10 μM) in segments pre-contracted 
with NA (1 μM) was not modified by orchidectomy, while the DHA supplemented diet 
increased this response (ANOVA, p < 0.01, Fig 6).  
 
Fig 6. Effect of orchidectomy and DHA supplemented diet in the vasodilator response to ACh 
curves in rat mesenteric arteries. Concentration-response curves to acetylcholine in 
mesenteric artery segments from control (C) and orchidectomized (Cx) rats fed with a control 
diet and from Cx rats fed with a DHAsupplemented diet (Cx DHA). Results (means + SEMs) are 
expressed as percentage of inhibition of the contraction induced by 1 μMnoradrenaline. The 
number of animals is indicated in parenthesis. 
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The effect of castration and DHA supplemented diet in this stage on NO contribution 
was studied in presence of the NOS inhibitor, L-NAME, which decreased the ACh induced 
response in arteries from the control group (ANOVA, p < 0.001, Fig 7A), did not modify those of 
orchidectomized rats (ANOVA, p > 0.05, Fig 7B), whereas it decreased Cx DHA group (ANOVA, 
p<0.0001, Fig 7C). Incubation with the COX inhibitor, indomethacin (10 μM), tended to 
increase the ACh-induced response in control arterial segments (ANOVA, p = 0.057 7-A), while 
increased the vasorelaxation in the orchidectomized group (ANOVA, p = 0.004, Fig 7B), and 
decreased it in Cx DHA group (ANOVA, p = 0.02, Fig 7C). 
 
 
 
 
 
 
Fig 7. Effect of L-NAME and indomethacin in the ACh-induced vasodilator response in rat 
mesenteric arteries. Effect of L-NAME (0.1 mM) or indomethacin (Indo, 10 μM) on the 
concentration response curves to acetylcholine in the NA-pre-contracted mesenteric artery 
segments from control rats with control diet (A), orchidectomized rats with control diet (B) and 
orchidectomized rats with DHA-supplemented diet (C). Results (means ± SEMs) are expressed 
as percentage of inhibition of the contraction induced by 1 μM noradrenaline. The number of 
animals is indicated in parenthesis.  
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Discussion 
There is compelling evidence which demonstrates the beneficial effect of n-3 PUFAs in 
vascular dysfunction for the prevention and treatment of cardiovascular disorders [21, 22]. 
Although the relationship between decreased levels of sex hormones and increased incidence 
of cardiovascular disease is established [28, 29], to date there are no studies examining the 
effect of diet supplemented with DHA when gonadal function is lost. Recently, we have 
reported positive modifications induced by a DHA-supplemented diet on lipid profile, redox 
status and vasodilator function of aorta from orchidectomized rats [24]. Taking into account 
that the mesenteric vascular bed importantly contributes to the control of blood pressure, in 
the present study we have focused on analyzing the effect of DHA-diet in the vascular function 
of rat mesenteric artery from orchidectomized rats.  
We previously published that the orchidectomy maintained for 5 months induces an 
increase on prostanoid release in mesenteric artery [30, 31] and aorta [17, 25], due to an 
oxidative stress augmentation. The results now presented are in agreement with these 
previous findings, since TXA2, PGI2, and PGE2 are increased from the 6 week post-
orchidectomy, as observed in aorta [24] and in mesenteric artery for the case of TXA2 [32]. 
However, DHA-supplemented diet decreased prostanoids release near to the control group 
levels. According with this data, the consumption of omega-3 fatty acid has been reported to 
inhibit the nuclear factor kappa B activation and of COX-2 expression [33], and to decrease the 
production of prostanoids [34]. Previous publications demonstrate that DHA competes with 
other PUFAs, such as the arachidonic acid, resulting in a decrease of prostanoid synthesis [35] 
and in an anti-inflammatory effect. 
NO release was decreased by castration, as reported earlier in aortas from 6 weeks 
postorchidectomized rats [32, 24]. The influence of the DHA-supplemented diet, showed a 
restoration in NO release levels, closely to the ones from the control group, as previously 
found in aorta [24]. However, DHA has been reported not to modify the release of NO in aged 
[36] and hypertensive [37] rats, indicating that the choice of the experimental model is crucial. 
NO bioavailability is strongly determined by the level of oxidative stress. It is already 
known that the loss of gonadal function increases the production of ROS [13, 20], like 
superoxide anion, a source of many other reactive oxygen intermediates, which quench NO. 
The results obtained in the present study show increased superoxide anion production in 
mesenteric artery from orchidectomized rats, which is in agreement with previous publications 
[13, 19], and that demonstrate the beneficial effects from male sex hormones in vascular 
function. Supplementation with the DHA diet diminished the superoxide anion levels near to 
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control levels, similar to those reported in the aorta of these animals [24]. In line with these 
results, is the ability of n-3 PUFAs to decrease superoxide anion production in mouse aorta 
[38] and human fibroblasts [39]. In addition, DHA has been reported to decrease oxidative 
stress in vascular [40], nervous [41] and immune [42] systems. All these data demonstrate the 
antioxidant properties of DHA in situations where oxidative stress is increased. 
Taking into account that: i) NO, prostanoids and ROS are able to modulate the vascular 
tone, ii) the DHA-supplement diet restores the altered production of these factors in 
orchidectomized rats, and iii) the important contribution of mesenteric artery in the control of 
systemic vascular resistance, the vasoconstrictor response mediated by the neurotransmitters 
released after EFS and the endothelium-dependent vasodilator response were analyzed. 
We observed that orchidectomy decreased the EFS-induced contraction, which is in 
agreement with that observed in mesenteric artery from 5 months-post-orchidectomized rats 
[13] in which the release of NA was not modified [18]. DHA-supplemented diet reversed the 
reduction in EFS-induced contractile response caused by orchidectomy. These actions seem to 
be specific on EFS-induced contraction since the contraction induced by 75 mM of KCl was not 
modified by the orchidectomy or DHA-diet. In this regard, the contractile response induced by 
potassium depolarization was not altered by a DHA diet in hypertensive rats [37]. Although, we 
have previously reported that the orchidectomy did not modify the release of neuronal NO 
[13] and NA [18], it would have been desirable to determine the neurogenic release of NA and 
NO. The authors acknowledge this limitation of the current study and, because of the 
intriguing and complex interactions among the different factors, this issue will be addressed in 
future studies. Nevertheless, it has been reported that DHA contained in fish oil did not 
significantly alter neuronal and cardiovascular control in normotensive and prehypertensive 
humans [43], while eicosapentanoic acid supplementation reduced cardiac noradrenaline 
concentration in diabetic rats [44], indicating that the cardiovascular benefits of omega-3 
depend on the initial stage of the pathology. Since 5 months post-orchidectomy modified the 
vasomotor responses induced by NO and NA, these responses were analyzed in mesenteric 
arteries after 6 weeks post-orchidectomy fed control and DHA-supplemented diet. 
Orchidectomy did not produce any relevant influence on NA-induced contractile response, 
suggesting that this castration period does not interfere with the response once released the 
neurotransmitter, which is consistent with some publications [45]. However, it contrasts with 
other studies in which orchidectomy decreased [13, 46] or increased [47] NA-induced 
contractile response. These variations might be attributed to castration and/or the animal 
model employed as mentioned above. Additionally, the DHA-supplemented diet did not 
influence NA sensibility in smooth muscle cells, since its response was similar to that produced 
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by orchidectomy. This result is in agreement with studies describing no modification by DHA 
on the contractile response after alpha-adrenoceptors activation [48, 49]. Regarding the 
vasodilator effect of NO, the SNP-induced response was analyzed. The vasodilator response 
was significantly increased by orchidectomy, which agrees with reports on mesenteric arteries 
of rats after 5 months post-orchidectomy [31]. This response was not modified by the DHA 
supplemented diet, meaning that PUFAs have no effect on NO sensitivity in smooth muscle 
cell, as it was found in aortic segments [24] as published earlier [36]. Therefore, one possible 
explanation for the recovering of the decreased EFS-induced response in orchidectomized rats 
fed with DHA, could be the decline in the oxidative stress and, in turn, the decreased 
vasodilator effect from the NO-derived products [13]. However, the participation of different 
mediators cannot be discarded, which would be the goal of future research. 
As stated before, the endothelium-dependent relaxation was also studied. In this 
regard, the ACh-induced response was unmodified by orchidectomy, as previously found in the 
aorta of these animals [24]. On the other hand, the diet supplemented with DHA significantly 
increased the endothelium dependent relaxation, caused by reduced oxidative stress, which 
increases NO bioavailability, as demonstrated by the levels of O2- and NO found in these 
arteries, and in aorta from a previous study [24]. 
To associate the participation of endothelial NO in the ACh- induced response, it was 
analyzed by using L-NAME, a NOS inhibitor. The decreased vasodilator response induced by 
ACh in the presence of L-NAME was grater in the rats fed with the DHA supplemented diet 
than in control and orquidectomized groups, evidencing that DHA increases NO participation. 
This response can be related to an increase of eNOS activation [50] aside from the increase in 
NO bioavailability, through the reduction of superoxide anion formation. The lack of change in 
the response from the orchidectomized group indicates a reduction in the participation of NO 
and the involvement from other vasodilator mechanisms apart from NO, such as prostanoids, 
when this is inhibited. Therefore, the role of prostanoids in ACh response was elucidated by 
incubation with the COX inhibitor, indomethacin. The increased response in orchidectomy 
suggests the involvement of vasoconstrictor prostanoids. For this reason, when prostanoids 
are removed by indomethacin the relaxation to ACh is greater, although the participation of 
other vasodilator factors cannot be discarded. However, in the DHA group vasodilator 
prostanoids are predominant, so ACh induced relaxation is smaller in the presence of 
indomethacin which suggests that the diet does improve more vasodilator than 
vasoconstrictor prostanoids. This is contrary to results found in aorta, where there was no 
modification of this response [24], indicating that the vascular effect of DHA in the relaxing 
response mediated by prostanoids depends on the vascular bed. It has been reported that 
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when prostanoid synthesis is inhibited, NO synthesis is modified [25] and viceversa; also, other 
factors could be working to compensate the loss of prostanoids [18]. 
In summary, orchidectomy was associated with endothelial dysfunction of mesenteric 
artery caused from increased oxidative stress, by means of an augmented formation of 
prostanoids and superoxide production, and a reduction in endothelial NO formation. Also, the 
neurogenic response was decreased. The DHA-supplemented diet decreased prostanoid and 
superoxide levels, at the same time that increased NO formation and bioavailability in 
orchidectomized rats, and recovered the neurogenic response that may account for a better 
regulation of vascular function. The results obtained in this study together with others 
previously reported [24] suggest that a DHA-supplemented diet may be helpful to treat 
cardiovascular disease, since this PUFA exerts beneficial effects, in addition to the lipid profile, 
on the function of both conduit and resistance arteries 
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Abstract  
Testosterone deficiency has been correlated with increased cardiovascular diseases, 
which in turn has been associated with increased oxidative stress. Several studies have 
considered cholesterol oxidation products (COPs) as oxidative stress biomarkers, since some of 
them play pro-oxidant and pro-inflammatory roles. We have previously described the 
cardioprotective effects of a dosahexaenoic acid (DHA) supplemented diet on the aortic and 
mesenteric artery function of orchidectomized rats. The aim of this study was to investigate 
whether impaired gonadal function alters the formation of COPs, as well as the potential 
preventive role of a DHA-supplemented diet on that effect. For this purpose, aortic and 
mesenteric artery segments obtained from control and orchidectomized rats, fed with a 
standard or supplemented with DHA, were used. The content of the following COPs: 7α-
hydroxycholesterol, 7β-hydroxycholesterol, 7-ketocholesterol, 5,6α-epoxycholesterol, 5,6β-
epoxycholesterol, cholestanetriol and 25-hydroxycholesterol, were analyzed by gas 
chromatography. The results showed that orchidectomy increased the formation of COPs in 
arteries from orchidectomized rats, which may participate in the orchidectomy-induced 
structural and functional vascular alterations already reported. The fact that the DHA-
suplemented diet prevented the orchidectomy-induced COPs increase, confirms the 
cardiovascular protective actions of DHA, which could be of special relevance in mesenteric 
arterial bed, since it importantly controls the systemic vascular resistance. 
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Introduction 
An important number of studies have shown a correlation between increased 
cardiovascular diseases with testosterone deficiency [1, 2]. It has been demonstrated that sex 
hormones regulate vascular function since sex hormones deprivation alters the release, 
function and cell signaling pathways of endothelial factors that could lead to vascular 
dysfunction. Thus, previous studies from our research group have shown that orchidectomy 
increased ROS production [3, 4] and prostanoids release [5-7], while the production of nitric 
oxide [8] and the antioxidant capacity [9-10] were reduced.  
The increased oxidative stress has been associated to the development of 
cardiovascular diseasses [11, 12]. Thus, oxidative damage of cellular membranes and enzymes 
by reactive oxygen and nitrogen species (ROS/RNS) has been described in cardiovascular 
diseases [13].  
Oxidative modification of cholesterol from cell membranes by ROS/RNS leads to the 
formation of cholesterol oxidation products (COPs), also called oxysterols. COPs can also be 
formed by enzymatic oxidation and/or by absorption from the diet [14-16]. Regardless of the 
source, COPs have the ability to induce disruption of fine structure, alteration of integrity, 
fluidity, and permeability, and loss of biomembrane functionality [17, 18]. 
Furthermore, oxysterols have been implicated in the pathogenesis of various diseases 
including cardiovascular diseases, cancer, neurological disorders, and aging [19-22]. COPs are 
able to modify low-density lipoproteins (LDL) and high-density lipoproteins (HDL) into pro-
atherogenic and pro-inflammatory forms. Oxysterols can also trigger pro-oxidative, pro-
inflammatory and cytotoxic reactions in the different cell types of the vascular wall, including 
endothelial cells [23], smooth muscle cells [24-25], fibroblasts [26], monocytes and 
macrophages [27]. Derived from such evidence, COPs have been proposed as potential 
biomarkers for non-invasive studies of oxidative stress in vivo [28]. 
Different studies have demonstrated that consumption of Omega-3 polyunsaturated 
fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may 
reduce the risk of developing cardiovascular diseases [29, 30]. The anti-thrombotic, anti-
inflammatory and vasoprotector effects of PUFAs on the cardiovascular system have been 
reported [31, 32]. Antioxidant propierties of DHA have been also demonstrated since it 
decreased ROS formation and bound to free radicals preventing tissue oxidation [33-35].  
Since it was reported that the lack of sex hormones increases oxidative stress and 
vascular inflammation, deteriorating factors that could lead to the development of CVD, it is 
possible that formation of oxysterols in the arterial wall could be modified by the loss of 
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gonadal function. On the other hand, Omega-3 PUFAs may act as a cardioprotective treatment 
in the oxysterol formation induced by orchidectomy. Therefore, the purpose of the present 
study was to determine the effects of orchidectomy on the formation of the main oxysterols 
recognized as products of cholesterol autoxidation [36] (7α-hydroxycholesterol, 7β-
hydroxycholesterol, 7-ketocholesterol, 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, 
cholestanetriol and 25-hydroxycholesterol) in the arterial wall of the aorta and mesenteric 
artery, as well as the possible preventive effect of a DHA-supplemented diet on COPs 
formation. 
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Materials and Methods 
Animals, diets and experimental groups.  
Male Sprague-Dawley rats (18-week-old) were purchased from Envigo (Mexico City). 
Rats were housed in stainless steel cages in a temperature-controlled (23 ± 2 °C) room, under 
12-hour light/dark cycles and standard feeding with fodder and water ad libitum. After 4 
weeks of adaptation, animals were fed a maintenance diet for rodents (2018S Teklad global 
18% protein rodent diets, Envigo, Madison, WI, USA) supplemented with fat (5%). The 
controls-diet groups were supplemented with sunflower oil (5%) and the DHA groups with 
4.7% MEG-3® (Ocean Nutrition Canada Ltd., Dartmouth, NS, CA) and adjusted to 5% with 
sunflower oil. Nutrient content and energy distribution of each diet is summarized in Table 1. 
After 2 weeks on the diet, animals were divided into two groups: control and orchidectomized 
males. Male sex hormone deprivation was induced by orchidectomy at 24 weeks-old under 
injectable anesthesia with Ketamine-Xylazine (80 mg/kg ket plus 10 mg/kg xil; IP). Rats were 
treated with 2 mg/kg meloxicam SC (Metacam 5 mg/mL; Boehringer Ingelheim) and with 50 
mg/kg ibuprofen immediately after surgery, via IP administration for 5 days. The observation 
of seminal vesicles atrophy confirmed successful surgery. Animals were maintained under the 
experimental diets for six more weeks. At the end of the treatment, rats were sacrificed by 
ether inhalation and decapitation. The mesenteric artery and the aorta were carefully 
dissected out, cleaned of connective tissue and placed in Krebs-Henseleit solution (KHS) 
containing, in mmol/L: NaCl 115, CaCl2 2.5, KCl 4.6, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 
11.1, Na2 EDTA 0.03 at 4 °C. The investigation was performed in compliance with the Guide for 
the Care and Use of Laboratory Animals published by the USA National Institutes of Health 
(NIH publication No. 85.23 revised 1985), and approved by the Ethical Committee of the 
Universidad Autónoma de Madrid according to directives of the Ministerio de Agricultura, 
Pesca y Alimentación of Spain (PROEX 202/16). 
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Table 1. Nutrient and energy content of experimental diets. 
Macronutrient 
Control diet 
(g/100g) 
DHA diet 
(g/100g) 
Crude protein 18.6 18.6 
Fat   11.2 11.2 
Carbohydrate (available)  44.2 44.2 
Crude Fiber                                                       3.5 3.5 
Neutral Detergent Fiber  14.7 14.7 
Ash 5.3 5.3 
Sunflower oil 5.0 0.3 
DHA+EPA 0 4.7 
Energy Density kcal/100g 310.0  310.0 
 
Determination of Cholesterol and COPs in arterial Tissue Samples 
Lipids extraction 
Two aortic and two mesenteric rings (ca. 3 mm length) from each animal (from the all 
experimental group of rats) were individually weighed, thawed and subjected to total lipid 
extraction, as described by Folch et al. [37] with some modification [16]. Briefly, arterial rings 
were homogenized in 1 mL of PBS at 4 °C containing BHT (0.05 %). Each arterial homogenate 
was mixed with 16 mL of the Folch solution (chloroform-methanol 2:1 v/v) and 0.01% BHT. 
Then, 3 mL of NaCl aqueous solution (0.73 %) were added. The resulting mixture was 
separated by centrifugation. The upper phase was discarded and the lipids were collected from 
the organic layer (lower phase). A mixture of chloroform-methanol-0.73% NaCl (3:48:47 v/v/v, 
7.5 mL) was added to the recovered phase and then left at 4 °C for 4 h to allow separation. The 
lower phase was recovered and then filtered through anhydrous sodium sulfate. Subsequently, 
the extract was resuspended in chloroform with BHT (0.02 %) and frozen at -20 ° C until used. 
Saponification 
Cold saponification was performed according to the method of Menéndez-Carreño et 
al. [38] to remove glycerides, free fatty acids and water-soluble impurities, as well as to release 
the esterified COPs. For sample preparation, each lipidic extract from the arterial tissue 
samples was added with 13 µg of the internal standard, 19-hydroxycholesterol (19-OH) 
(disolved in n-hexane:isopropanol, 4:1 v/v) for COPs quantification and with 1 mg of 5α-
colestane (disolved in n-hexane: isopropanol, 4:1 v/v) as an internal standard for the 
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quantification of cholesterol. The mixture was then dried under stream of nitrogen and mixed 
with 3 mL of a KOH solution in methanol (4 mol/L or 4 N) with BHT (0.05 %), wrapped with 
aluminium foil and subjected to orbital shaking (300 rpm) at room temperature for 18 h to 
produce saponification. 
For extraction of the unsaponifiable matter, 10 mL of dichloromethane and 5 mL of 
citric acid (0.1% in double-distilled water) were added to each sample, and mixed vigorously in 
a vortex. The diethyl ether fraction was then separated by centrifugation. The aqueous layer 
(supernatant) was discarded and the organic phase was washed with portions of 5 mL citric 
acid (0.1%, v/v) solution until clear. The organic phase from the samples was dried over 
anhydrous sodium sulfate. The organic solvent was evaporated with a rotary evaporator at 50 
°C to remove the dichloromethane. The unsaponifiable extract was dissolved in diethyl ether in 
a conical vial and dried under nitrogen flow for the subsequent quantification of cholesterol 
and COPs. 
Analysis of total cholesterol by gas chromatography 
For cholesterol determination, 10% of the unsaponificable matter solution was dried 
under nitrogen flow and subjected to silylation according to Sweeley et al. [39]. A 
pyridine:hexamethyldisilazane:trimethylchlorosilane (5:2:1, v/v/v) mixture was added (0.3 mL) 
and heated at 40 °C for 20 min. The mixture was then dried under a stream of nitrogen and 
dissolved in 1 mL of n-hexane. 
Analyses were performed on an Agilent 7820A gas chromatograph. 1 µL of sample was 
manually injected in split mode (1:1). Separation of the compounds was performed on a Perkin 
Elmer PE-5 capillary column (30 m x 0.32 mm d.i. x 1 µm film thickness coated with 5% -
phenyl-methylpolysiloxane). The oven temperature was programmed from 280 °C to 300 °C at 
a rate of 10 °C/min, and mantained for 30 min. The injection and detection port temperatures 
were set at 325 °C. UHP nitrogen was used as the carrier gas at a rate of 1.5 mL/min. 
Total cholesterol from the arterial tissue lipidic extracts was quantified by the internal 
standard method, using 5α-cholestane. Identification of the cholesterol peak in the samples 
was carried out comparing the retention times with that from the standard. Quantification of 
cholesterol was performed using a calibration curve. 
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Purification and derivatization of COPs 
The remaining 90% of the unsaponificable matter were dried under nitrogen stream 
and re-suspended in 300 μL of n-hexane:ethyl acetate (95:5, v/v) and purified by NH2 SPE 
cartridges, previously equilibrated with 3 mL n-hexane deied with anhydrous sodium sulfate at 
the bottom. The cartridge was eluted with the following solvent sequence: 6 mL of n-
hexane:ethyl acetate (95:5, v/v), 10 mL of n-hexane:ethyl acetate (90:10, v/v) and 10 mL of 
acetone. The COPs were eluted from the NH2 SPE cartridge with the acetone fraction according 
to the method of Rose-Sallin et al. [40]. The purified COPs were dried under nitrogen flow and 
silylated, according to the method of Sweeley et al. [39], and dissolved in 50 μL of n-hexane. 
Analysis of COPs by gas chromatography 
One microliter of the silylated COPs was manually injected into the GC under the same 
conditions used for the determination of total cholesterol. Total COPs were quantified using 
19-hydroxycholesterol (19-OH) as internal standard. The COPs identification in the samples 
was performed by comparison of the retention times with those of the COPs standards and the 
quantification was performed by calibration curves, as it was done for cholesterol. 
Reagents  
All analytical grade solvents and reagents were supplied by Tecsiquim (Mexico City) 
and from Sigma-Aldrich (Mexico City). For identification and quantification of each COP the 
internal standards utilized were 19-hydroxycholesterol (internal standard for the quantification 
of COPs), 5α-cholestane (internal quantification standard for cholesterol), Cholest-5-en-3β-ol 
(cholesterol), cholest-5-en-3β-ol-7-one (7-ketocholesterol), 5α,6α-epoxycholestane-3β-ol 
(5,6α-epoxycholesterol), 5β,6β-epoxycholestane-3β-ol (5,6β-epoxycholesterol), cholestane-
3β,5α,6β-triol (cholestanetriol), cholest-5-en-3β,7β-diol (7β-hydroxycholesterol), and cholest-
5-en-3β,25-diol (25-hydroxycholesterol). Cholest-5-en-3α,7α-diol (7α-hydroxycholesterol) 
standard was supplied by Steraloids (Newport, CT, USA).  
Solid-phase extraction (SPE-NH2) cartridges (500 mg amino-propyl stationary phase/3 
mL) were purchased from Phenomenex (Grace Discovery Sciences, Deerfield, IL, USA). The 
silylation mixture was prepared with dried pyridine, hexamethyldisilazane and 
trimethylchlorosilane, from Sigma.  
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Statistical analysis 
All values are expressed as the mean ± SEM (Standard Error of the Mean) of the five 
animals used. For each value, the mean of the cholesterol and COPs quantification -obtained in 
each of the two arteries from the same animal- was calculated. Statistical analysis of COPs 
concentration was performed by one-way analysis of variance (ANOVA) followed by Tukey’s 
multiple comparison test. For body weight, statistical analysis was done using paired Student’s 
t-test. A p value of less than 0.05 was considered significant. Data were analyzed using the 
GraphPad Software (San diego, CA, USA). 
Results 
Animal body weight  
Animals remained healthy and behaved similarly well throughout the experiment. 
Before the experimental diets (control or DHA) were administered, body weight was evaluated 
in the four groups of animals, showing no statistical differences among the groups (Table 2). 
The average weight gain at the end of 8 weeks under the experimental diets was similar for all 
the experimental groups, which is consistent with our previously published data [9]. 
Table 2. Body weight (g) in control (C) and orchidectomized (ORX) rats fed with a control or 
DHA-supplemented diet. 
 Body weight (g) 
Animal group Before diet After diet 
C Control  418.5 + 11 463 + 10* 
C DHA  385.1 + 12 435 + 19* 
ORX Control  384.6 + 13 437 + 12* 
ORX DHA  409.2 + 16 423.4 + 16* 
Values are means + SEMs. Number of animals per group, n = 5. 
*Indicates differences with its respective groups before diets. 
Cholesterol content in aorta 
Orchidectomy significantly increased cholesterol levels in the aortic tissue compared to 
the control group fed with the control diet (Fig. 1). The DHA-supplemented diet caused a 
significant decrease in cholesterol levels in the aorta from orchidectomized animals. Samples 
from control rats fed with the DHA-supplemented diet showed similar levels to those found in 
the control rats fed with the control diet. 
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COPs content in aorta 
Total COPs levels significantly increased in the orchidectomized group, and decreased 
in orchidectomized animals fed the DHA-supplemented diet (Fig. 1). DHA supplementation did 
not stastically modify total COPs content in control rats. 
Consistent with the above trend, orchidectomy caused a significant increase in the 
concentration of the studied COPs in aortic segments: 7α-hydroxycholesterol (7α-OH), 7β-
hydroxycholesterol (7β-OH), 7-ketocholesterol (7-KC), 5,6β-epoxycholesterol (5,6β-E), 5,6α-
epoxycholesterol (5,6α-E), 25- hydroxycholesterol (25-OH), and cholestanetriol (CT) (Fig. 1).  
The DHA-supplemented diet decreased COPs levels in the aortic tissue of 
orchidectomized rats, except 7β-OH which did not reach stastistical difference (Fig. 1). 
However, the DHA-diet to control animals tended to increase the concentration of all analyzed 
COPs. 
The proportion in the concentrations of the analyzed COPs in relation to the total COPs 
was similar in the different groups included in this study. CT was the most abundant COP (ca. 
30% from total COPs), followed by 7β-OH (ca. 20% from total COPs), 7α-OH (ca. 18%), 5,6β-E 
(ca. 12%). 7-KC, was higher in both orchidectomized groups (fed with control and DHA-
suplemented diet) the ratio remained above the control groups by ca. 8-10%. The proportion 
of 5,6α-E was similar in all groups, being ca. 5% of total COPs. 25-OH could not be detected in 
the control rats fed the control diet and for the other groups this COP was detected in very 
small concentrations (≤1%). 
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Cholesterol content in mesenteric artery  
The content of cholesterol in mesenteric artery was significantly increased by 
orchidectomy and the DHA-supplemented diet significantly decreased those levels (Fig. 2). The 
DHA-diet to control rats did not statiscally modify the content of cholesterol in mesenteric 
artery tissue (Fig. 2).  
COPs content in mesenteric artery 
Similar results were observed for COPs content in mesenteric artery respect to those 
found in aorta from these animals. Total COPs content increased significantly in samples from 
orchidectomized animals, compared to the rest of the groups. The control animals fed with the 
control diet as well as those fed with the DHA-supplemented diet showed similar COPs levels. 
Again, DHA supplementation decreased COPs content in orchidectomized animals (Fig. 2). 
Orchidectomy significantly increased 7α-OH, 7β-OH, 7-keto, 5,6β-E, 5,6α-E, 25-OH, and 
CT content (Fig. 2) compared to the rest of the groups included in the study. As observed in 
Fig. 2, 25-OH content from control rats fed with the control diet was not detected. The same 
ocurred with 7-KC, which was only detected in minimal amounts in the orchidectomized group, 
whereas it was practically absent from the mesenteric artery tissue in the other groups. 
In the mesenteric arteries from the orchidectomized animals fed with the DHA 
supplemented diet the concentration of COPs decreased significantly, except for 7β-OH, 
similarly to that found in aortic tissue (Fig. 2). DHA supplementation in control animals tended 
to decrease the concentration of all the analyzed COPs (7α-OH, 7β-OH, 7-KC, 5,6β-E, 5,6α-E, 
25-OH, and CT), unlike the observed in aorta. 
Regarding the distribution of COPs content in mesenteric artery tissue, CT was the 
most abundant COP (ca. 30%) followed closely by the 7α-OH and 7β-OH, which showed similar 
proportions between the same groups, arround 20% of total COPs. Next in proportion is the 
5,6β-E representing ca. 15% of total COPs, with a slightly higher proportion in the control 
group (19%). The 5,6α-E represents about 10% of the total COPs, dropping to 6% in the 
orchidectomized animals fed the DHA-supplemented diet. 25-OH was practically absent, since 
it could not be detected. In the case of 7-KC, it was only detected in the orchidectomized group 
at very low concentrations. 
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Discussion 
This study shows, for the first time, that the loss of gonadal function induced an 
increase in the formation of COPs in both aorta and mesenteric artery wall. The preventive 
action of a DHA-supplemented diet on the orchidectomy-induced COPs formation is also 
demonstrated. These results are in agreement with data previously reported on both the 
effects of orchidectomy and the beneficial role of a DHA-supplemented diet.  
Regarding the results specifically associated to orchidectomy, we have previously 
reported that the loss of gonadal function of rats induced an overproduction of ROS in aorta 
[3] and mesenteric artery [4], as well as an increase in the serum content of cholesterol, LDL-
cholesterol and triglycerides [9]. It is known that the cholestesterol embeded on the lipid 
bilayer from the cell membranes is prone to oxidation by ROS [41, 42] which could explain the 
increased formation of COPs derived from autoxidation processes described in this work. 
However, oxidation during sample processing can not be ruled out, despite of the utilization of 
BHT (0.05 %). Likewise, it is important to consider that conversion to COPs other than those 
analyzed may exist. It is well known that the preferential site of oxidation of cholesterol by 
highly reactive species is at C7 having a relatively weak carbon-hydrogen bond. Moreover, the 
unique cholesterol double bond between carbons 5 and 6 comprises a vulnerable site for 
oxidation by free radicals. The most abundant non-enzymatic cholesterol oxidation products 
present in most tissues are 7α-OH, 7β-OH, 7-KC, and 5,6α-E and 5,6β-E, respectively [43, 44] 
induced by ROS and RNS [45], which is in line with the findings from the current study, except 
for 7-KC, which was only detected in mesenteric arteries from orchidectomized rats. CT is one 
of the most abundant oxysterols, derived from cholesterol by oxidation via formation of 5,6α-E 
and 5,6β-E as intermediates [46]. The very low detection leves of 25-OH may be attributed to 
its primarily enzymatic origin, since this oxysterol is generally not considered to be a significant 
autoxidation product of cholesterol. In addition, the reported levels of 25-OH in most tissues 
are extremely low [36]. Determination of COPs content can vary depending on the extraction 
and/or measurement methods, although very low COPs levels under physiological conditions 
have been reported [47]. In this sense, the 7-KC, 7α-OH and 5,6α-E content -referred to total 
cholesterol- reported in the present study were similar to those described in human aorta [48] 
and coronary arteries [49]. However, the relative7-KC, 7α-OH, 7β-OH, 5,6α-E and 5,6 β-E 
content found in our study are higher than those described in human aorta and carotid artery 
[49, 50].  
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On the other hand, COPs are known to trigger oxidative stress by increasing the 
generation of superoxide anion [51, 52], and down-regulating the expression/activation of 
Nrf2 [53] Consistent with these results, many studies have reported increased COPs levels in 
the membranes of cells subjected to oxidative stress, as it has been detected in patients with 
diabetes mellitus [54], hiperlipidemia [28], chronic inflammatory processes and chronic renal 
failure [55]. In this regard, the oxysterol clearance mechanisms are probably less efficient in 
those situations [44], as it was observed in orchidectomized rats in wich the antioxidant 
activity was decreased [9]. Zhang et al. [56] demonstrated that castration decreased enzimatic 
antioxidant activity (SOD and glutathione peroxidase) and increased malondialdehyde levels, 
an indicator of lipid peroxidation. In contrast, other studies found that castration did not 
increase lipid peroxidation [57]. These discrepancies could be attributed to differences in the 
animal model used, since the maintenance period of gonadectomy determines the induced 
alterations [8, 58]. However, it is important to emphasize that the experimental model used in 
this study is the same as that used in our two previous studies [9, 10] and provides relevant 
information about the key role of the COPs in the orchidectomy-induced modifications of 
factors, additional to ROS, which regulate vascular function.  
It has been mentioned above that different cardiovascular risk factors, such as 
hypertriglyceridemia, hypertension, diabetes, obesity and overweight, have been associated to 
COPs content in human serum [15]. In agreement with these results, COPs induced increased 
blood pressure, serum triacylgycerols as well as body fat index in Wistar rats [59]. On the other 
hand, the induction of hypertension to rabbits by coarctation of the aorta showed an 
enhancement of COPs content in both plasma and aortic tissue 60]. In addition, Ares et al. [61] 
indicated that COPs promoted the stimulation of MAPK in human aortic smooth muscle cells, 
which could partially explain the activation of the MAPK sinaling pathway reported in 
hypertension after tyrosin kinase receptor transactivation [62]. In this regard, our group has 
described the activation of MAPK and AKt pathways in mesenteric arteries of 
orchidedctomized rats, in which the transactivation of EGFR was involved [8]. In this context, 
these results would indicate that the increase in the formation of COPs may participate in the 
orchidectomy-induced structural alterations that, in the long term, can lead to the 
development of hypertension, as it occurs in aged-orchidectomized rats. 
Apart from these effects, COPs alter prostaglandin synthesis and stimulate platelet 
aggregation, an important process facilitating atherosclerosis and thrombosis [42]. Likewise, 
different COPs induced the expression of COX-2 [63] and the release of prostaglandin E2 [64] 
and prostaglandin J2 [65], considered as pro-inflammatory events. Accordingly, it has been 
described that orchidectomy also leads to a pro-inflammatory environment by increasing 
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prostanoid production in rat aorta [6, 8, 9] and mesenteric arteries [7, 8, 10] most likely as a 
consequence of increased oxidative stress produced during the experimental conditions.  
Nitric oxide is also a critical molecule in vascular function, and the inhibition of 
endothelial NO-synthase by COPs has been described [52, 66], which is also in agreement with 
the decreased NO formation observed in aorta [9] and mesenteric artery [10] from 
orchidectomized rats. Although the decrease of NO production by COPs seems to be 
demonstrated, studies addressing the influence of COPs in the vascular function have shown 
contradictory results, since inhibition [67, 68] or no modification [69, 70] of endothelial-
dependent vasodilation by 7-KC and 7α-OH-cholesterol have been reported. In our 
experimental model, orchidectomy did not alter the acetylcholine-induced response in aorta 
or mesenteric artery, since factor/mechanisms other than NO are simultaneously working to 
maintain a proper function [4, 7].  
These results can be summarized in that orchidectomy induced an increase of the 
oxidative stress and anti-inflammatory mediators, and a deterioration of the lipid profile, 
which is accompanied by an increase in the formation of COPs. Interestingly, cholestanetriol -
the most abundant COP in all samples, especially in arteries from orchidectomized rats- has 
been reported to be one of the most cytotoxic oxysterols in different cell lines such as rabbit 
aortic smooth muscle cells [71], mouse L cells [72], Chinese hamster V79 lung fibroblasts [26], 
human monocytic cells (U937), colonic adenocarcinoma cells (CaCo-2) and hepatoma liver cells 
(HepG2) [73]. However, it is important to point out the cytotoxic effects reported for different 
COPs other than cholestanetriol, also in different cell lines, related to vascular and nervous 
systems that contribute to the pathogenesis of cardiovascular [52, 74] and neurodegenerative 
[19, 20] diseases. 
It has been suggested that generation of some oxysterols can be reduced in the 
presence of antioxidants [43] by scavenging ROS. For instance, supplementation of vitamin E to 
diabetic patients can decrease 7-KC and 7β-OH levels [75]. Likewise, Uemura et al. [76] found 
that apoptosis induced by 7β-OH and 7-KC in vascular endothelial cells was prevented by α-
tocopherol. DHA exhibits potent anti-oxidant properties which attenuate ROS overproduction 
in endotelial cells [77] and enhances the overall antioxidant status [78]. Recently, the ability of 
DHA to prevent ROS overproduction and oxiapoptophagy induced by 7KC, 7β-OH, and 24-OH 
in oligodendrocytes was demonstrated [79]. De Medina et al. [80] found that DHA inhibited 
cholesterol-5,6-epoxide hydrolase activity, that catalyzes the conversion of 5,6α-E and 5,6β-E 
to its product CT, which exerts important citotoxic effects. Also, DHA showed protective effects 
on COPs-induced cell death [33]. These results agree with our findings, since the DHA-
supplemented diet to orchidectomized rats prevented the rise in COPs formation caused by 
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orchidemtomy. Thus, the levels of COPs were near to those measured in control rats fed the 
control diet. Interestengly, the DHA-supplemented diet restored the increased contents of 
COPs induced by orchidectomy, similarly how it restores the lipid profile, and the redox and 
inflammatory status altered in this particular condition [9,10]. These results are in agreement 
with the cardioprotective effects of DHA widely reported through its anti-inflammatory [31] 
and anti-oxidant activities [33-35]. It has been recently reported that DHA, one of the main 
fatty acids of the Mediterranean diet, attenuates the 7-KC-induced toxic effect on microgial 
cells [81]. Based on all this information, human dietary habits deserve important consideration 
and comsumption of a Mediterranean diet could prevent the consequences of an increased 
oxidative stress that occurs in diverse physiopathological situations. However, something 
different seems to occur with the DHA-supplemented diet to the control animals, in which a 
tendency to increase COPs content was observed in the rat aorta. This result is in line with a 
previous report, in which the involvement of vasodilator prostanoids in the Ach-induced 
response in aorta from control rats was switched to vasoconstrictors after the DHA-
suppelemented diet [9]. Overall, these results indicate that DHA-supplementation exerts 
cardiopotective effects, especially in pathological conditions, which seems to be reasonable 
since the homeostatic mechanisms work to maintain proper function in healthy subjects 
without any nutritional supplement.  
In summary, we describe here the detrimental effects caused by the lack of sex 
hormones in the rise in lipid peroxidation, providing new information on the damage on lipid 
components responsible of maintaining membrane properties and cell signaling in different 
pathways involved in the vascular function of aorta and mesenteric artery, already published 
[9,10]. The preventive effect of a DHA-supplemented diet on lipid peroxidation, which 
promotes the maintenance of vascular homestasis, is also shown. In this regard, it is important 
to note that the results observed in the mesenteric artery, together with those related to 
vasomotor function [10], are of special relevance since this vascular bed importantly 
contributes to the control of the peripheral vascular resistance and therefore to the regulation 
of blood pressure. The present findings reveal the interest in conducting clinical studies with 
DHA in patients with decreased levels of sex hormones (elderly patients and/or prostate 
cancer patients undergoing androgen deprivation therapy) who display cardiovascular risk 
factors. 
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Conclusions 
In summary, the data obtained in the present study indicates that the DHA 
supplemented diet prevents vascular dysfunction produced by the loss of gonadal function in 
male rats, due to specific actions on: 
1. Lipid profile. The DHA supplemented diet restored the lipid profile negatively 
affected by the orchidectomy. 
2. COPs. The DHA supplemented diet prevented the orchidectomy-induced COPs 
increase. 
3. Redox status. The DHA supplemented diet exerted antioxidant properties, since it 
decreased hydrogen peroxide formation and increased antioxidant capacity in 
both serum and aortic tissue. In addition DHA-supplemented diet decreased the 
production of superoxide anion (increased by orchidectomy) in aorta and 
mesenteric artery, which could account for the restored NO production and 
bioavailability in these arteries. 
4. Vascular inflammation. DHA exerts anti-inflammatory properties by decreasing 
prostanoid production in both aorta and mesenteric artery.  
The DHA induced effects here described could be involved in the maintencance of 
vascular function through: i) the improvement of the neurogenic response in mesenteric artery 
and ii) the participation of hyperpolarizing mechanisms in aorta, which contributes to preserve 
vascular function. 
Overall, these results show that the DHA-supplemented diet exerts a cardioprotective 
effect in physiopathological conditions in which vascular dysfunction exists. 
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Conclusiones 
En resumen, los datos obtenidos en el presente estudio indican que la dieta 
suplementada con DHA previene la disfunción vascular producida por la pérdida de la función 
gonadal en ratas macho, debido a acciones específicas sobre: 
1. El perfil lipídico. La dieta suplementada con DHA restauró el perfil lipídico, 
afectado negativamente por la orquidectomía. 
2. Los productos de oxidación del colesterol. La dieta suplementada con DHA 
previno el aumento de COPs inducido por la orquidectomía. 
3. El estado redox. La dieta suplementada con DHA ejerció propiedades 
antioxidantes, ya que disminuyó la formación de peróxido de hidrógeno y aumentó 
la capacidad antioxidante tanto en el suero como en el tejido aórtico. Además, la 
dieta suplementada con DHA disminuyó la producción del anión superóxido 
(aumentada por la orquidectomía) en aorta y arteria mesentérica, lo que podría 
explicar la restauración en la producción y biodisponibilidad del NO en estas 
arterias. 
4. La inflamación vascular. El DHA ejerce propiedades antiinflamatorias al disminuir 
la producción de prostanoides tanto en aorta como en arteria mesentérica. 
Los efectos inducidos por el DHA aquí descritos podrían estar implicados en el 
mantenimiento de la función vascular a través de: i) la mejora de la respuesta neurogénica en 
la arteria mesentérica y ii) la participación de mecanismos hiperpolarizantes en la aorta, lo que 
contribuye a preservar la función vascular. 
Globalmente, estos resultados muestran que una dieta suplementada con DHA ejerce 
un efecto cardioprotector en condiciones fisiopatológicas en las que existe disfunción vascular. 
